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Comparative Analysis of the Diagnostic Accuracy of Cell Block 
Technique to Conventional Smears in Minimally Invasive Procedures of 
Pulmonary Lesions. 
Abstract: 
Cell blocks prepared from residual tissues fluids and fine needle 
aspirations can be useful adjuncts to smears for establishing a more 
definitive cytopathologic diagnosis. Conventional smear cytology, however 
carefully prepared, leaves behind residue that is not further investigated but 
that might contain valuable diagnostic material. The cell block technique 
employs the retrieval of small tissue fragments from the residual sample 
which are processed to from a paraffin block. Multiple sections can be 
obtained from this block. This allows for immunostains and other studies to 
be performed similar to the paraffin sections produced in histopathology. 
They can be particularly useful for categorization of tumors on cytology 
specimens that   may not be possible from smears themselves.  
Aim: 
Preparation of cell blocks from fluids (pleural fluid, bronchial washings) and 
residual FNAC material. To compare the diagnostic accuracy of cell block 
technique with conventional smears. To use immunohistochemistry on cell 
block for subtyping tumors and in cases suspicious for malignancy. 
 
Methods:  
In this prospective study, 100 samples which include 50 pleural 
effusion samples, 35 bronchial wash samples and 15 imaging guided FNAC 
samples were subjected to make both conventional smear and cell block. 
Cell blocks were made by plasma thromboplastin method. Both the 
techniques were compared based on the cellularity, architecture, quality and 
diagnosis. Immunohistochemistry was performed in cell blocks to confirm 
and subtype malignant tumors. 
Results: 
Abundant cellularity was seen in 31% of the cases by cell block and 
only 10% of the cases had abundant cellularity by conventional smear. 
Excellent architecture equivalent to histology was seen in 15% of the cases 
by cell block and this was not seen in conventional smear. By conventional 
smear, benign, suspicious of malignancy, malignant and non-diagnostic 
cases were 66%, 8%, 15%, 11% respectively. By cell block 71% benign, 
24% malignant, 5% non-diagnostic. Combining both conventional smear and 
cell block, the diagnostic yield of malignancy increased by 9%. 
Immunohistochemistry was performed in 18% of the cases to confirm and 
subtype the malignancy. 
Conclusion: 
Cell block is a very good adjunct to conventional smear study in the 
better yield of cellularity and architecture with an advantage to do 
immunohistochemistry, leading to better diagnosis of malignancy in the 
fluids and residual FNAC samples of pulmonary lesions. Ideally cell block 
technique should be used in routine practice for cytological diagnosis. 
Key words: conventional smear, cell block, immunohistochemistry. 
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INTRODUCTION 
 Cell block (CB) technique was first described by Bahrenberg in 
1896.This is an old method for evaluation of body cavity fluids. The cell 
block technique employs the retrieval of cells or small tissue fragments from 
any body fluid including pleural fluid, bronchial wash and imaging guided 
fine needle aspiration cytology (FNAC) specimens. 
Cytology of pulmonary lesions provide valuable diagnostic 
information by non or minimally invasive procedures
1
. Direct sampling 
methods like bronchoscopy and fine needle aspiration (FNA) increases the 
ability to diagnose pulmonary diseases by cytology
2
. Pleural fluid cytology 
is one of the commonly performed investigations in the diagnosis of 
malignant lesions, staging and prognosis. 
 The cytodiagnosis by conventional smears (CS) have got some 
drawbacks due to overcrowding of cells, cell loss leading to less cellularity 
and different laboratory processing methods
3
. To overcome these drawbacks 
cell block technique was employed.Cell blocks from fluid specimenscan be 
prepared by using agar or plasma thrombin method, the cellbutton formed is 
formalin fixed and processed routinely like histopathological specimens. 
The main advantages of cell block techniques are preservation of 
tissue architecture and possibility to obtain multiple sections from the same 
material for special stains and immunohistochemistry
4
. The material 
preserved by cell block also improves the diagnostic accuracy. 
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There is an increasing need for additional diagnostic techniques such 
as immunohistochemistry (IHC), to define a specific cell lineage on cytology 
and FNAC specimens
5,6
. Immunohistochemistry is a highly effective 
ancillary tool that can be used on cell block to distinguish adenocarcinoma, 
squamous cell carcinoma and small cell carcinoma.Cell block increases 
accuracy, reproducibility and minimizes the rate of unclassified carcinomas. 
ADVANTAGES OF CELL BLOCK
7
: 
1. The method is simple, reproducible and readily adaptable in routine 
hospitallaboratory. 
2. It bridges the gap between cytology and histology. 
3. There is adequate cellularity, cell aggregates and microscopic tissue 
fragments are easily recoverable. 
4. Preservation of architectural pattern like cell balls, papillae and three 
dimensional clusters. 
5. Concentration of cellular material in one small area that can be 
evaluated at aglance with all cells lying in the same focal plane of 
microscope. 
6. Delineation of nucleus and cytoplasmic details. 
7. Intact cell membranes and crisp chromatin details. 
8. Cell block sections are suitable for histochemical stains and IHC. 
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Hence the present study was undertaken to assess the utility and 
diagnostic accuracy of cell-block technique in the diagnosis of pulmonary 
lesions by minimally invasive diagnostic procedures like bronchial 
washings, pleural fluid samples and image guided fine needle aspiration 
cytology of lung mass.  
 4 
 
AIM& OBJECTIVES 
1) Preparation of cell blocks from fluids (pleural fluid, bronchial 
washings) and residual FNAC material from pulmonary lesions.  
2) To compare the diagnostic accuracy of cell block technique with 
conventional smears. 
3) To use immunohistochemistry on cell block for subtyping tumors and 
in cases suspicious for malignancy. 
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REVIEW OF LITERATURE 
Bennet in 1848 gave an account on tumor cells in effusion fluids in his 
publication that led to the development of cytopathological diagnosis of 
body cavity fluids
8
. In 1867, Luke and Klebs gave a description of malignant 
cells in effusion
9
. Kanhouwa et al, correlated cytopathology and 
histopathology in the typing of lung carcinoma. He showed a correlation of 
cytopathology and histopathology of 77.5%
10
 in his study. 
The cytological examination of the fluids and effusions has 
increasingly gained acceptance in clinical medicine, with the surge of 
minimally invasive procedures to such an extent that a positive diagnosis is 
often considered the definitive test and obviates explorative surgery. It is 
important not only in the diagnosis of malignant lesions, but also help in 
staging and prognosis. Lack of morphological details of the representative 
cells contributes to considerable difficulties in making conclusive diagnosis 
on conventional smears. 
Cell blocks prepared from residual tissue fluids can be used as an 
adjunct to smear, for establishing a more definitive cytopathological 
diagnosis. The technique is simple, safe, cost-effective and reproducible 
even in resource limited settings
11
. The use of cell blocks is being 
increasingly advocated in the diagnostic work-up of patients. The routine use 
of this technique remains confined to a limited number of centers. 
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HISTORIC EVOLUTION OF CELL BLOCK TECHNIQUE: 
A variety of cell block techniques have been in use for over a century. 
Since Bahrenburg and Mandlebaum described their technique of embedding 
and sectioning cellular sediments in 1896, there have been a number of 
reports concerning the formed elements in serous effusions
8
.  
In1917, malignant tumors were diagnosed in paraffin sections of 
centrifuged exudates to make specimens more readily interpretable even by 
histopathologists. Karnanchowand Bouin, modified and developed plasma 
embedding "cell block" technique
12
. 
Zemansky in 1928, established the definite arrangement of the cells as 
acini and papillae or of aggregates of abnormal cells to be of malignant 
nature.Chapman and Whalen, Schlesinger and others set up similar criteria 
for the diagnosis of malignant tumor cells in serous effusions
13
. 
THE ADVANTAGES OF THE CELL BLOCK PROCEDURE: 
• Less cellular dispersal, which permits easier microscopic observation 
than do traditional smears
14
. 
• Less difficulty in interpretation as background shows no excess blood 
on microscopic observation. 
• Recognition of histological patterns of diseases that sometimes cannot 
be identified reliably in conventional smears
14
. 
• Possible to study multiple sections by routine and special staining. 
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• They allow for the evaluation of ancillary studies such as 
immunocytochemistry, in-situ hybridization tests (FISH/CISH) and in-
situ polymerase chain reaction (PCR)
15
. 
• Possibility of storing slides for retrospective studies.  
ANATOMY AND HISTOLOGY: 
The pleura is a thin, glistening, slippery serous membrane lining the 
thoracic wall and diaphragm, as the parietal pleura. It is then reflected onto 
the lung as the visceral pleura.The pleural cavity is a potential space between 
the two layers, containing a thin film of fluid. 
On light microscopy,the pleura is typically divided into a mesothelial 
layer, a thin submesothelial connective tissue layer, a superficial elastic 
layer, a loose sub pleural connective tissue layer anda deep fibroelastic 
layer
16
. 
The major portions of the upper and lower respiratory tract are lined 
by a pseudostratified and ciliated columnar epithelium. The morphology of 
benign cellular components of respiratory tract material has been well 
described in the literature by Farber and associates, Woolner and McDonald, 
Koss and Frost and associates
17-19
. 
The components of respiratory specimens (bronchial aspirates or 
brushings and FNAs) may be divided into epithelial cells (squamous, ciliated 
columnar epithelium and goblet cells), macrophages, leukocytes, inanimate 
components and organisms. 
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NORMAL CYTOLOGY: 
EPITHELIAL COMPONENTS: 
Ciliated Bronchial Columnar Cells
20
: 
Ciliated columnar cells are uniform, columnar or prismatic shape, 
ending in a tail and forms monolayered tissue fragments. The cells are 
columnar with basally placed nucleus, one or more nucleoli and a fine 
granular chromatin. The cell clusters on en-face gives a honeycomb 
appearance. Ciliated columnar cells are usually seen in bronchoscopic brush 
lavage, aspirate, transbronchial or tracheal fine needle aspirations. 
Goblet Cells: 
These cells are seen as mucus producing cells in the bronchial 
epithelium. Cells have single or multiple vacuoles filled with mucus within 
the cells.These cells are seen in bronchial brushings of patients affected with 
chronic bronchitis and bronchiectasis and not very commonly encountered in 
the washings
21
. 
Alveolar Epithelium: 
These cells are normally not seen in the cytologic material. In reactive 
conditions they may appear in bronchoalveolar lavages (BAL) and fine 
needle aspirations but mostly misinterpreted as alveolar macrophages. 
Reactive alveolar cells are singly scattered with central nucleus, small 
nucleoli and vacuolated cytoplasm. These cells are differentiated from 
macrophages by the absence of any phagocytosed material within the cells. 
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Mesothelial cells in pleural fluid: 
Mesothelial cellsare sheets of polygonal cells that are usually 
separated from each other by clear gaps or “windows”.The cells are oval or 
spherical in shape, about 20 µm in diameter with eosinophilic cytoplasm and 
round to oval centrally placed nucleus with conspicuous nucleoli.Reactive 
mesothelium can appear atypical and be misinterpreted as neoplastic. The 
origin of these cells from the mesothelial surface is best documented in cell 
blocks that show the linear nature of the clusters cut “on edge”.The outer 
edges of such clusters are usually composed of rows of cells showing smooth 
borders or “scalloping”. 
Non-Epithelial Cellular Elements
22
: 
Non-epithelial inflammatory cells like macrophages, lymphocytes, 
neutrophils and eosinophils may be seen even in the samples from normal 
individuals. The type of cells present in the sample varies depending on the 
method of sampling, processing and history of smoking in the patient. Large 
number of inflammatory cells predominantly pulmonary macrophages and 
neutrophils are seen in bronchoalveolar lavage (BAL) specimens of smokers 
affected by chronic bronchitis. The type of the inflammatory cell, its number 
and distribution may vary depending on the nearby neoplasm or a reaction to 
the injury. 
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Macrophages and Giant Cells: 
The cells may have a single nucleus or may be multinucleated.The 
nucleus is oval or kidney shaped with small nucleoli and granular fine 
chromatin. Macrophages are often multinucleated; the nuclei within each 
multinucleated cells are of similar size and morphology.They account for 
60–90% of the cells in the pulmonary specimens and are very commonly 
seen in BAL specimens. Inflammatory conditions such as pneumonia, 
granulomas, bronchitis and malignant tumors with extensive necrosis have 
abundant macrophages. 
 The cytoplasm of the macrophages may contain intrinsic and extrinsic 
elements. Hemosiderin, blood cells, lipofuscin and lipid are few intrinsic 
elements seen within the cytoplasm of the alveolar macrophages. In smokers, 
tan brown granules are seen which should be differentiated from 
siderophages. The granules in the siderophages are finer and stain positive 
for iron.   
Extrinsic elements like carbon particles, silica and asbestos fibers may 
be seen within the macrophages. Multinucleated giant cells are seen as a 
reaction to fungal or mycobacterial infection.  
Siderophages: 
The hemosiderin granules seen within the siderophages are golden 
brown in colour and are refractile.Hemosiderin in the siderophages are 
positive for Prussian blue stain and this helps to differentiate it from 
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lipofuscin and melanin.Siderophages are seen in Wegener granulomatosis, 
idiopathic pulmonary hemosiderosis, hemorrhage, congestive heart failure 
and infarcts. 
Polymorphonuclear Leukocytes: 
Acute inflammatory cells, like neutrophils are seen in many 
pathological conditions or may be even as contaminants from the oral cavity. 
Neutrophils are seen more commonly in the malignant neoplasms with a 
necrotic background and also a variety of conditions like abscess, acute 
bronchitis and bacterial pneumonia. 
Lymphocytes: 
 Small mature lymphocytes can commonly be seen in the specimens 
procured by bronchial brushings, bronchial lavage or bronchoalveolar 
lavage.Abundant lymphocytes are seen in granulomatous lesions caused by 
tuberculosis, many viral infections, hypersensitivity pneumonitis and drug 
induced reactions. 
 Any inflammatory condition associated with abundant lymphocytes 
may mimic small cell carcinoma or leukemia/lymphoma of the lungs. The 
mature lymphocytes in the inflammatory conditions are smaller than the 
neoplastic cells in small cell carcinoma. Pleomorphism of the neoplastic 
cells, necrosis and nuclear molding is seen in the small cell carcinoma, 
which is absent in the chronic inflammation. These two conditions can also 
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be differentiated by neuroendocrine markers, which show positivity in small 
cell carcinoma. 
Eosinophils: 
 These inflammatory cells are not normally seen in the pulmonary 
specimens. In normal individuals, less than 1% of the eosinophils may be 
seen in BAL samples. They  appear usually after antigenic stimulation such 
as in bronchial asthma. Abundant eosinophils are seen in conditions like 
bronchial asthma, hypersensitivity pneumonitis and in eosinophilic 
pneumonia. Infection with parasites and fungus also cause antigenic 
stimulation leading to increase in eosinophils. 
NON-CELLULAR ELEMENTS: 
Curschmann Spirals: 
These are mucous casts that form corkscrew like spirals with a central 
core. From the axis of the core, filamentous structures radiate 
perpendicularly.With Papanicolaou stain, it stains pale cyanophilic or 
eosinophilic and stains black with silver. 
 Sputum of the heavy smokers commonly contains Curschmann spirals 
in the medium-sized to small bronchioles. They can also be seen in patients 
with chronic bronchitis, bronchial asthma and other obstructive lung 
disease
23
. 
  
 13 
 
Charcot–Leyden Crystals: 
Cytoplasmic granules of the eosinophils condense to from needle-shaped or 
rhomboidal structures of variable sizes.In many conditions with abundant 
eosinophils, Charcot–Leyden crystals can be seen.Bronchial asthma and 
allergic pneumonitis are few conditions associated with these crystals. With 
Papanicolaou these crystals have well defined refractile edges and they stain 
green or red. 
REACTIVE CHANGES: 
Squamous metaplasia and atypia: 
Exposure to chemical, physical or biologic agents causes sustained 
injury to the respiratory tract columnar epithelium. This leads to squamous 
metaplasia of the respiratory epithelium. These cells appear as miniature 
keratinized squamous cells.The metaplastic cells are oval or elliptical shaped 
with bright cyanophilic or orangeophilic cytoplasm and pyknotic uniform 
nucleus when stained with Papanicolaou. Atypia may be prominent in cases 
of chronic inflammation, tuberculosis, abscesses, etc., which can mimic 
carcinoma. Squamous metaplastic cells are most commonly seen in smokers 
and patients with chronic infections like fungal infections, usual interstitial 
pneumonia (UIP) and organizing pneumonia. These cells should be 
mentioned in the cytopathology report as it can also undergo dysplastic 
changes and later may develop into squamous cell carcinoma
24
. 
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Reactive bronchial cells: 
Reactive changes in bronchial cells are usually associated with 
hyperplasia of the bronchial epithelium and it appears as cellular cohesive 
sheets.The individual cells are enlarged and have poorly defined cell borders. 
The reactive cells have oval to round nuclei and prominent nucleoli.Some 
cells show variation in the size of the nucleus. The nucleus contains fine, 
bland granular, evenly distributed chromatin. The prominent nucleoli, which 
is uniform in shape and size present in the nucleus of the reactive cells is an 
important characteristic feature. These cells are seen associated with many 
conditions including pneumonia (Viral pneumonias), bronchitis, 
instrumentation, bronchial asthma, bronchiectasis, chemotherapeutic agents, 
exposure to toxins and radiation. 
Goblet cell hyperplasia: 
Goblet cells undergo hyperplasia due to chronic inflammation. 
Hyperplastic goblet cells are seen associated with bronchial asthma, chronic 
bronchitis and bronchiectasis. They may be seen as clusters or singly 
dispersed cells in the procured cytologic material. Particularly in bronchial 
brushings they are seen as clusters. The individual cells are enlarged with 
single large or multiple smaller mucinous vacuoles with a basally located 
flattened nucleus.  
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Reactive Terminal Bronchial/Alveolar Epithelium: 
The reactive alveolar epithelial cells form small clusters and papillary 
arrangement of the cells may be seen in type II pneumocytes surrounded by 
abundant macrophages. The individual cells are smaller in size with enlarged 
nucleus. Viral pneumonias, interstitial lung disease, infarction, organizing 
pneumonia, asbestosis and some drug-mediated changes induce the 
macrophages and type II pneumocytes to proliferate. Proliferating type II 
pneumocytes have cytoplasmic vacuoles and may form papillary clusters 
which mimics acinar, papillary or bronchiolo-alveolar type of well 
differentiated adenocarcinoma. 
Reactive macrophages may have large nuclei with prominent nucleoli 
and cytoplasmic vacuoles. It is difficult to differentiate it from 
adenocarcinoma. The presence of a spectrum that encompasses normal and 
atypical macrophages with similar nuclear shape and chromatin 
characteristics, speaks against adenocarcinoma. 
Reserve Cell Hyperplasia: 
Bronchial reserve cells are located close to the basement membrane of 
the mucosa between the basal parts of ciliated columnar cells. These cells are 
small round to polygonal multipotent cells that undergoes hyperplasia with 
exposure to smoke and chemical irritants. They are seen in specimens 
procured by brushing or washing of large bronchi, forming small cohesive 
clusters or tissue fragments rather than isolated cells. These cells are small, 
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round to polygonal with scant cyanophilic cytoplasm and round to oval 
nuclei that have a uniformly distributed bland chromatin. Reserve cells 
clusters are associated with few ciliated bronchial cells which can be 
differentiated from the reserve cells by its abundant cytoplasm. Some 
metaplastic squamous cells can also be observed around the rim of some of 
the larger tissue fragments. Small cell carcinoma is the most important 
differential diagnosis and it is differentiated from reserve cell clusters by 
large amount of isolated cells in a necrotic background. 
Creola Bodies:  
Creola bodies are sheets or thick 3-D tissue fragments of reactive 
bronchial cells. These are exfoliated papillary fragments of reactive 
bronchial cells that may be seen in the patients with chronic bronchitis, 
particularly due to asthma. The fragments are also often seen in other 
reactive or inflammatory lesions of the bronchial mucosa. The clusters of 
bronchial mucosa are partially covered by ciliated respiratory epithelium. 
Because of the thickness of the tissue fragment, accurate visualization of 
details of the crowded nuclei is difficult. When visualized around the edge of 
the fragment, the nuclei are bland with evenly distributed chromatin, smooth 
nuclear outline and uniform nuclear membrane. Small nucleoli may be 
present. Identification of cilia is facilitated by partial closure of the 
microscope’s condenser. 
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THERAPY-INDUCED CHANGES: 
Radiation Therapy: 
Radiation therapy given for metastatic and primary breast carcinomas 
are the most common cause for the exposure of the lungs to radiation
25
. The 
respiratory epithelium undergoes changes like cytomegaly with nuclear 
enlargement and degenerative changes both in the nucleus and cytoplasm. 
The individual cells are bizarre shaped, amphophilic cytoplasm with 
vacuoles and debris and smudged nuclear chromatin. 
Chemotherapy: 
Alveolar pneumocytes and the respiratory columnar epithelium are 
usually affected by chemotherapy. The changes seen in the columnar cells 
are similar to that of the changes caused by radiation therapy. Some drugs, 
such as bleomycin affects the squamous cells and causes atypia, while many 
other drugs causes alveolar hyperplasia
26
. 
RESPIRATORY INFECTIONS: 
Mycobacterial Infections: 
Tuberculosis caused by M. tuberculosis or M. avium intracellulare is a 
common mycobacterial disease worldwide
27,28
. Emerging drug resistant 
strains complicates the treatment of the disease. Cytologic smear shows 
abundant lymphocytes and histiocytes with eosinophilic necrotic material. 
Inflammatory cells are absent in immunocompromised individuals. 
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Occasionally Langhans giant cells are also seen. In chronic cases, the cells 
lining the tuberculous cavity show atypia.  
In immunosuppressed and elderly patients with upper and lower 
respiratory tract infections many other species of bacteria like legionella, 
actinomycosis and nocardiosis can be seen as a superimposed infection. 
Viral Infections: 
Many viruses produce some similar cytologic changes, which can be 
commonly seen but nonspecific. Techniques like immunocytochemistry, 
DNA in-situ hybridization, culture or polymerase chain reaction (PCR) is 
needed to identify these viruses. 
Herpes Simplex Infection
29
: 
Cell clusters or isolated cells show cytopathic changes. The cells have 
nuclear inclusion which is well defined with a halo and condensed chromatin 
against the nuclear envelope. These cells are surrounded by acute 
inflammatory cells in a necrotic background.  
Cytomegalovirus Infection:
 
In immunocompromised patients, cytomegalovirus infection can be 
commonly seen. The virus affects pneumocytes, macrophages, bronchial 
epithelial and endothelial cells. The cells show marked enlargement with 
both cytoplasmic and nuclear inclusions, surrounded by a very scant 
inflammatory cells. The cytoplasmic inclusions are cyanophilic, small and 
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variable in size. Nuclear inclusions are mostly single, described as owl eye 
inclusion with a large halo
30
. 
Mycotic Infections: 
Respiratory organs particularly in immunosuppressed individuals 
(AIDS and transplant patients) are commonly affected by mycotic infections. 
Cytologic examination and special fungal stains such as Gomori 
methenamine silver (GMS) or per-iodic acid Schiff (PAS) can be used in the 
detection of the infections. Microbiologic testing such as cultureand PCR 
can also be used in the diagnosis of the infection. 
Candidiasis: 
These organisms can be in the form of pseudohyphal filaments, 
irregular and10–15µm in diameter or Yeast buds which are oval in shape and 
2–4µm in diameter. They cause opportunistic infections in 
immunocompromised patients. It evokes an acute inflammatory response of 
neutrophils. 
Aspergillosis: 
In immunosuppressed individuals, many pulmonary lesions are 
produced by the inhalation of the spores of Aspergillus spp. The spectrum of 
lesions include localized mycetoma (aspergilloma), diffuse invasive 
aspergillosis, abscesses, eosinophilic pneumonia or allergic 
bronchopulmonary aspergillosis (ABPA)
31
. Aspergillus is a thin septate 
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hyphae with a uniform branching pattern at 45◦ and is 3–6 µm in diameter. 
Calcium oxalate crystals, eosinophils and lamellated mucus are seen. 
Zygomycosis (Phycomycosis): 
These fungal hyphae are non-septate, broad with a variable diameter 
of 6-50µm and branching pattern at 90◦. These fungi are more commonly 
seen in paranasal sinuses in immunocompromised patients. 
Histoplasmosis: 
This infection is symptomatic in immunocompromised patients, which 
is otherwise mostly asymptomatic. This infection is acquired by the 
inhalation of the soil infected by bird droppings. The organism is 2–4µm in 
diameter in size with a thin capsule which is positive for PAS and GMS. The 
organism is located intracellularly within the macrophages and the 
neutrophils. Extracellular organisms trigger a granulomatous reaction. 
NEOPLASTIC PULMONARY LESIONS: 
Lung cancer is the most common non-cutaneous malignancy reported 
worldwide and 80–85% of it is caused by smoking
32
. Asbestos exposure, 
radiation exposure, nickel, arsenic, cadmium, beryllium and vinyl chloride 
are other factors which are attributed to cause lung cancer. 
Classification of lung cancer: 
Most lung cancers arise from the lining epithelium of the bronchioles 
and bronchi, but few tumors also arise from the alveolar lining epithelium. 
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These tumors are commonly described as bronchogenic carcinomas. They 
may be classified into the following main groups: 
• Carcinomas exhibiting predominantly squamous differentiation, 
classified as squamous or epidermoid carcinomas. 
• Carcinomas forming glandular patterns, mimicking bronchi or alveoli, 
classified as bronchogenic adenocarcinomas of various types or as 
bronchioloalveolar carcinomas. 
• Carcinomas composed of undifferentiated small cells, resembling the 
basal or reserve cells of the bronchial epithelium, forming the group of 
small cell carcinomas. 
• Carcinomas composed of undifferentiated or poorly differentiated 
large cells, some of which may exhibit glandular or squamous 
differentiation or even endocrine features. 
• Rare types of carcinomas including tumors with endocrine features. 
Although a more detailed classification was proposed for the World 
Health Organization by an expert pathology panel of the International 
Association for the study of Lung Cancer (Travis et al, 1999), the simple 
classification shown here is adequate for cytological diagnosis
33
. 
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CLASSIFICATION OF PRIMARY LUNG CARCINOMAS AND RELATED TUMORS
33
 
Squamous carcinoma 
Keratinizing (well-differentiated) 
Poorly differentiated (epidermoid) 
Large-cell undifferentiated carcinoma
*
 
Small-cell undifferentiated carcinoma 
Oat cell carcinoma 
Intermediate cell type 
Adenocarcinoma 
Adenocarcinoma of central bronchial origin 
“Acinar” carcinoma 
Solid carcinoma with mucin formation 
Papillary carcinoma 
Bronchioloalveolar carcinoma 
Adenosquamous carcinoma 
Mucoepidermoid carcinoma 
Spindle and giant-cell carcinoma 
Neuroendocrine tumors 
Carcinoid 
Atypical carcinoid (well-differentiated neuroendocrine 
carcinoma) 
Large-cell carcinoma with endocrine differentiation 
Rare carcinomas 
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Squamous cell carcinoma: 
 Squamous cell carcinoma mostly occurs centrally, arising in the 
segmental, lobar, or main stem bronchi. This type of tumor can also present 
with extensive areas of necrosis with a central cavity. 
Cytologicaly, these tumors are characterized mainly by singly 
scattered cells and loose clusters. The individual cells show marked 
pleomorphism with well-defined borders, hyperchromatic nucleus with 
irregularly dispersed chromatin. Bizarre shaped cells like tadpole or spindle 
shaped cells, caused due to cytoplasmic thinning are also seen. Intense 
hyaline appearance of the cytoplasm of the cells is an indicator of 
keratinization. Small tissue fragments can be seen in FNAC and bronchial 
specimens
20
.In poorly differentiated tumors, the tissue fragments gives a crab 
like appearance with very few cells showing keratinization. 
Histologically, the well-differentiated keratinizing squamous cancers 
are composed of sheets of cells attempting to form squamous epithelium, 
often with abundant keratin formation and keratin pearls. Central 
keratinization and necrosis is characteristic, particularly in larger tumors
33
. 
Adenocarcinoma: 
Histological features in adenocarcinomas, the cells are arranged in 
glandular, papillary or bronchioloalveolar pattern with large amount of 
mucin in the background. 
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Cytologically, the exfoliated malignant cells are large, usually round 
or polygonal, occasionally columnar and are found singly, scattered or in 
clusters with a three-dimensional papillary or spherical configuration with 
tumor cells superimposed upon each other. Cytoplasm of the well-preserved 
cells is moderate in amount, often finely vacuolated, faintly staining, usually 
basophilic with round to ovoid vesicular nucleus that is placed eccentrically 
with a macronucleoli
34-36
. 
Bronchoalveolar carcinoma: 
These tumors arise in bronchiolar or alveolar epithelium of peripheral 
lung tissue and may present as a localized mass or masses in lung 
parenchyma. The proliferating tumor cells are uniform and orderly in 
appearance and utilize the alveolar framework for support so that initially the 
basic architecture of the lung remains well preserved, so-called lepidic 
spread. Tumor cells often form papillary projections into the alveolar space.  
Cytologically, the neoplastic cells are arranged in ball-like three 
dimentional cell clusters or papillary structures
37
. Cells have round to oval 
uniform nucleus with granular chromatin and inconspicuous nucleoli. 
Small cell carcinoma: 
 Histologically, small-cell (oat cell) carcinoma is composed of sheets 
of small, round, ovoid or spindle cells that characteristically seem separated 
from each other.  
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Cytologically, the cells are mostly arranged in loose clusters with very 
few singly scattered cells. Cells have very scanty cytoplasm, round to 
irregular shaped nucleus with hyperchromatic dense chromatin. The cells are 
very small equal to the one and half times the size of a small lymphocyte. 
The tumor cells show very prominent intercellular molding and necrosis
38
. 
Large cell carcinoma: 
Histologically, the large-cell undifferentiated bronchogenic 
carcinomas are composed of broad, diffusely infiltrating sheets of usually 
moderate size tumor cells with moderate to abundant cytoplasm .They are 
without substantial squamous or glandular differentiation, although they may 
exhibit focal features of squamous cancer or adenocarcinoma, sometimes 
side by side.  
Cytologically, the cells are arranged as syncytial groupings and single 
cells.The individual cells are large with ill-defined cell borders, round to 
lobulated nucleus with hyperchromatic and irregularly dispersed chromatin 
with prominent nucleoli. 
Adenosquamous carcinoma: 
Adenosquamous carcinoma is defined as a carcinoma with both 
squamous and adenocarcinomatous areas. The minor component should 
account for atleast 10% of the whole tumor. 
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PLEURAL EFFUSION: 
The pleural effusion associated with benign disorders mostly has a 
nonspecific cytologic picture. 
Acute pleuritis: 
Bacterial infection causing pneumonia also causes secondary infection 
of the pleura leading to acute pleuritis and later pleural empyema. The 
pleural fluid becomes creamy, purulent pale yellow with foul smell. 
Cytologic smears shows very high cellularity and predominantly composed 
of polymorphonuclear leukocytes. Metastatic malignancy may also present 
with abundant acute inflammatory cells which sometimes masks the 
malignant cells. So a careful search for the malignant cells should be done in 
suspected cases of malignancy. Special stains can also be used to 
demonstrate the bacteria in case of infection. 
Eosinophilic Effusions: 
In a pleural effusion if the eosinophil count is 10% or more of the 
nucleated cells it is considered to be eosinophilic effusion. Between 5% and 
16% of exudative effusions are eosinophilic effusions
39
.On cell blocks when 
stained with eosin and hematoxylin, the granules of the eosinophils are 
stained brightly eosinophilic.Pneumothorax and hemothorax produced due to 
procedures like thoracenteses are the common cause for eosinophilic 
effusion
40
.Pulmonary infarction,drug reactions,Churg-Strauss syndrome and 
 27 
 
parasitic infections are other causes which leads to the eosinophilic 
effusion
41
. 
Lymphocytic Effusions: 
In pleural effusion, the presence of lymphocytes is a nonspecific 
finding, but they are commonly present. Cytologic smears from the pleural 
effusion are usually highly cellular and show abundant dispersed 
lymphocytes and few mesothelial cells and histiocytes
42
. The most common 
cause of lymphocytic effusion is tuberculosis and malignancy. Lymphocytic 
effusion is also caused by the obstruction of the lymphatics by the 
malignancy without spreading to the pleural surfaces or the pleural 
malignancy produces only lymphocytic response without shedding the 
malignant cells into the effusion
46
. The mere absence of malignant cells in 
the lymphocytic effusion does not rule out malignancy. 
Rheumatoid pleuritis: 
Rheumatoid pleuritis is caused in less than 5% of patients with joint 
disease.Pleuritis in a patient with rheumatoid arthritis develops either before 
or after the appearance of the joint disease or develops along with the joint 
disease
44, 45
. 
Malignant pleural effusions
47
: 
Are seen in association with  
1) Primary Tumors of Mesothelium (Mesothelioma) 
2) Metastatic tumors 
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Malignant Mesotheliomas- 
It is most commonly due to occupational exposure to asbestos and 
carries bad prognosis. Histologically it is composed of large malignant cells 
with abundant eosinophilic cytoplasm and large but pale vesicular nuclei 
forming glandular andtubular structures, often separated from each other by 
connective tissue septa.Papillary excresevences are common
47
.  
Metastatic Tumors- 
Lung tumors in males and breast tumors in females are the malignant 
diseasesmost commonly responsible for malignant pleural effusion. Besides 
the lung and pleura, the primary common sites of malignancy in males were 
the gastrointestinal tract, liver and pancreas. In females, the breast, lung, 
ovary, pancreas, gastrointestinal tract and uterus were in descending order of 
frequency
48
. 
General characteristics of tumor cells in effusions that may help in 
identifying nature and site of primary lesions: 
Recognition of the cells by size: 
The size of tumor cells may vary gently according to tumor type. To 
determine the size of a suspect cell, a comparison must be made with 
identifiable cell types suchas erythrocytes, lymphocytes or mesothelial cells. 
In large cell types, cells are significantly larger than normal 
mesothelial cells.Some mesotheliomas, metastatic carcinomas of various 
types, malignant melanomas and sarcomas belong to these groups. 
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In small cell type, tumor cells are much smaller than mesothelial cells. 
Lymphomas, Neuroblastomas, Wilm’s tumor and Oat cell carcinoma belong 
to thisgroup. 
Medium sized cells are approximately same in size to mesothelial 
cells. Carcinomas of mammary, Lung, Gastric, Pancreas, or Prostatic origin 
may have this presentation. 
Cell Aggregates: 
Malignant tumors, principally adenocarcinoma of various primary 
origin form three-dimensional cell aggregates or gland like structure with a 
central lumen. 
Cell Products and cytoplasmic Features: 
Products of metabolic activity of cells, such as mucus, melanin 
pigment, psammoma bodies, cytoplasmic cross striations and 
intracytoplasmic glandular inclusions(Target cell, Bulls eye cells) help in 
identifying the primary site of tumor. 
Nuclear features: 
Most of malignant cells in fluids have enlarged nuclei and increased 
nuclear cytoplasmic ratio.Nuclei are usually round to oval with smooth 
borders. Occasionally nuclei are irregular or indented in lymphomas. Large, 
irregularly shaped, single or multiple nucleoli are frequently observed in 
cancer cells. Presence of mitotic figure is a presumptive evidence of cancer. 
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Abnormal or multiple mitotic figures are more reliable identifiers of cancer 
cells in effusion. 
Nuclear Cytoplasmic Inclusion: 
Sharply demarcated clear areas within the nucleus correspond to 
cytoplasmic invaginations. It is seen in cells of metastatic melanoma, thyroid 
cancers and pulmonary adenocarcinoma. 
Multiple Sex Chromatin (Barr) Bodies: 
In female patients, two or more sex chromatin bodies in the same 
nucleus are virtually diagnostic of cancer, because they document the 
presence of an abnormal chromosomal complement. This observation is 
particularly helpful in the diagnosis of some cases of mammary carcinoma
47
. 
TECHNIQUES TO OBTAIN SAMPLES: 
Bronchoscopy: 
Gustav Killian developed the rigid bronchoscope in nineteenth 
century, which laid the foundation for visualizing the mucosal surfaces of the 
bronchi and sampling of tissue and evaluation of cellularity. Walloch 
summarized the important advances of flexible catheters passed into the 
bronchi under fluoroscopy and the development of the flexible fiberoptic 
bronchoscope
49
. 
The main bronchus divides into second-order (lobar) bronchi, which 
divides further into third-order (segmental) bronchi. The part of the lung 
supplying the third-order bronchus is a bronchopulmonary segment. 
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Bronchial Washings: 
Bronchial wash cytology is a widely accepted safe, simple and 
minimally invasive technique to evaluate cell morphology. Bronchoscopic 
washing, brushing and fine needle aspirations may complement tissue 
biopsies in the diagnosis of lung cancer
17, 50
. The bronchial washing is a safer 
technique and the malignant cells can be readily recognized and typed
33
. It is 
a valuable investigation in situations where biopsy procedure cannot be 
attempted due to high risk of hemorrhage or in more peripheral sites. 
Bronchial washings by bronchoscopy are performed to detect and 
characterize, ill-defined premalignant or malignant lesions and for the 
identifying microbiologic pathogens. Specimens are obtained with a suction 
apparatus that aspirates secretion. Washings are collected by instilling 3–
5mL of a balanced salt solution and re-aspiration of the material. Smears are 
prepared by centrifugation or membrane filtration. The collected samples are 
centrifuged and the residual cellbutton is embedded in paraffin for histologic 
sectioning.To be considered as adequate bronchial brushing or lavage, 
abundant ciliated columnar cells must be present. In patients with pulmonary 
malignancies, alveolar hemorrhage, interstitial lung disease and pneumonia, 
BAL and washings are done. 
Bronchial Brushings: 
With flexible fiberoptic bronchoscope, a suspected lesion may be 
visualized and brush cytology material can be examined. Similar technique 
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as for preparation of cell block from the bronchial washings is used for 
bronchial brushings also. 
Fine-Needle Aspiration: 
Direct tissue sampling for the diagnosis of peripheral pulmonary 
lesions is essential in most patients for decisions regarding treatment and can 
be accomplished by fine needle aspiration cytology (FNAC). FNAC can be 
performed via the airway (endobronchial/transbronchial FNAC) or chest 
wall (CT-guided percutaneous FNAC). Transbronchial FNAC is useful for 
the diagnosis of primary pulmonary lesions that lie beneath the bronchial 
surface
51
. 
The respiratory tract cytology is obtained by radiologic imaging 
guided precise visualization and localization of the lung mass and sampling 
of such visualized lesions with a fine bore needle passed into them
52-54
. A 
syringe fitted with a fine needle is passed through the chest or bronchial wall 
into the pulmonary mass under the guidance of bronchoscopy, computed 
tomography or fluoroscopy. The aspirated specimen is subjected for analysis 
by conventional smear. 
Indications and Contraindications: 
Stitik and Heaston associates summarized the following indications55-56 
1) Inoperable but suspected lung cancer. 
2) Probable metastatic lesion due to a solitary pulmonary mass. 
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3) Malignant extra-pulmonary primary and a solitary pulmonary 
nodule. 
4) Patient with suspected lung cancer, refusing exploratory 
thoracotomy. 
5) Patient failing to respond to anti-tuberculous therapy. 
6) A suspected infectious process, particularly in an 
immunocompromised patient. 
7) A suspected superior sulcus tumor. 
8) Multiple pulmonary mass lesions. 
9) An undiagnosed pulmonary mass. 
10) A patient who is suspected of having lung cancerand who has 
produced five consecutive earlymorning deep-cough specimens of 
sputum and one bronchial brushing or washing that have been 
negative for malignant tumor cells. 
Contraindications for FNAC: 
1) Debilitated or uncooperative patient orthose with uncontrollable 
cough. 
2) Patients with bleeding diathesis, onanticoagulation therapy or 
suspected vascular lesion or pulmonary hypertension. 
3) Patients with echinococcal cyst. 
Complications: 
Pneumothorax, hemothorax and hemoptysis. 
 34 
 
Thoracentesis: 
This is a technically simple and safe procedure, when done in a patient 
without bleeding tendencies or after correction of coagulopathy. For 
diagnostic studies, 50-100 ml of fluid is sufficient. It is done at the bedside 
with the patient sitting upright comfortably and the arms and head supported 
by an adjustable table.The upper border of moderate effusion is identified by 
stony dull percussion note and loss of tactile and vocal fremitus. 
Thoracentesis is performed in the interspace below this level. The skin is 
cleansed with iodophor or an antiseptic solution and the underlying tissues, 
including the periosteum of the rib is infiltrated with local anaesthetic. A 20 
gauge needle is inserted 5-10 cm lateral to the spine above the superior 
border of lower rib in order to avoid the intercostal vessels or nerve injury. 
The needle is advanced with continuous gentle suction until the parietal 
pleural membrane is penetrated and adequate fluid is obtained. In case of 
minimal or loculated effusion the needle is inserted under ultrasound 
guidance
7
. 
CELL BLOCK TECHNIQUE: 
Cell block technique or paraffin embedding of sediments of fluids is 
among the oldest methods of preparing material for microscopic 
examination. The method uses histologic techniques for processing and thus 
offers one major advantage: multiple sections of the material are processed 
for routine stains, such as hematoxylin and eosin, and for special stains that 
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may serve for immunocytochemistry and for identification of mucin, 
melanin, or other cell products, and identification of bacteria and fungi. 
With the development of excellent cell preparation techniques, the cell 
block technique has been abandoned. This neglect is not justified and the 
residual material remaining aftercytologic preparations must be subjected to 
cell block technique. The residual material contains valuable evidence of 
tissue fragments for processing by cytologic techniques. Richardson et al 
(1955) have shown that additional diagnoses of cancer can be obtained in 5% 
of fluid specimens by cell block sections of residual material, supplementing 
the smear technique
57
. The additional benefit of cell block technique is the 
recognition of histologic patterns of disease that sometimes cannot be 
reliably identified in smears or filter preparations. 
Aspiration biopsy material (FNA), sputum, effusions, urine sediment 
and material from the gastrointestinal tract are suitable for cell block 
processing, as all tissue fragments incidentally obtained during any other 
diagnostic cytologic procedure. 
The best cellular details in cell blocks are obtained with Bouin's 
fixative or picric acid fixative. However, a more practical fixative is buffered 
formalin that allows a wide range of additional procedures. 
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Methods: 
1. Fixed Sediment Method
17
: 
1) Mix sediment or tissue fragments with the fixative. Fibrin clots can be 
wrung out and placed in fixative separately. Centrifuge this mixture. 
2) Pour off supernatant and drain tube well by inverting the tube on a 
paper towel. 
3) Carefully remove the packed sediment or fibrin clot from the test tube 
by means of a spatula and wrap it in lens paper. Place wrapped 
sediment in a carefully labeled tissue cassette. 
4) Put tissue cassette into a jar of the same type of fixative used before. 
Process as tissue biopsy. 
2. Bacterial Agar Method (3% Agar): 
Steps 1 through 3 are the same as for the fixed sediment method. 
4) If sediment becomes hard and packs well, gently remove it from the 
test tube with a spatula and place it on a paper towel with the conical 
side up. 
5) Slice the sediment in half from the top to the bottom of the conical clot 
with a scalpel. 
6) Place the cut side of the packed sediment in a small pool of melted 
agar that has been spread on a glass slide or in a Petri dish. Cover all 
exposed areas of the sediment with melted agar and let stand a few 
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minutes to harden. Care must be exercised to avoid bubbles in the 
agar. 
7) Trim the excess agar from the sediment and slice the sediment in half 
from the top to the bottom of the conical clot with a scalpel and place 
it in a tissue cassette. 
8) If sediment does not pack well or only a small amount is available 
after completion of steps 1 through 3, a few drops of melted agar 
should be added to the test tube and mixed thoroughly with sediment. 
After the agar hardens, gently remove the agar button from the test 
tube and place it in a tissue cassette. 
Preparation of Agar: 
The 3% agar is prepared by dissolving 3 g of bacterial agar in 100 ml 
of boiling water. The melted agar may be colored with a small amount of 
food coloring to ensure contrast with the paraffin. The dissolved agar should 
be poured into individual sterile glass tubes with a screw cap. Cap the tubes 
loosely until the agar cools and hardens. When the agar has cooled, tighten 
the caps and place the tubes in a refrigerator until ready for use. When it is 
needed, melt the agar in a 60°C water bath. Discard unused agar at the end of 
the day. 
3. Simplified Cell Block Technique: 
In 1988, Krogerus and Anderson
58
 introduced a simple technique of 
cell block preparation from materials obtained from effusions, fine-needle 
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aspiration and brushings. The technique is unique in that, the procedure is 
carried out in the sample tube, ensuring minimal cell loss. No transfer of 
cells to a cassette is necessary, eliminating the need for wrapping paper, 
agar, or thrombin. The procedure is as follows: 
• In a 50-ml plastic, conical centrifuge tube, fix cell sample with 50% 
alcohol for 1 hour. 
• Spin sample at 300 g for 7 minutes and pour off supernatant. 
• Re-suspend cell pellet in 3 ml of acetone for 10 minutes. 
• Spin sample at 300 g for 10 minutes. Pour off acetone. 
• Place tubes for 1 hour on a warm plate (not more than 60°C). 
• Add melted paraffin to the dry, warm pellet. 
• After paraffin has solidified, tap the bottom of the tube to remove 
block. 
• Cut and process the conical end of the paraffin block as you would 
any tissue section. 
4. Plasma-Thrombin Clot Method: 
• Thoroughly mix a few drops of blood plasma obtained from blood 
bank with the fresh unfixed sediment. Plasma may be colored with a 
small amount of food coloring to ensure contrast with the paraffin. If 
the sample was prefixed with alcohol, the sediment must be washed 
several times with a balanced salt solution, since alcohol inhibits the 
clotting action of plasma and thrombin. 
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• Add the same number of drops of thrombin solution as of the pooled 
plasma and mix well. Thrombin is prepared by adding 5000 
units(topical, 1 vial) with 10 ml of distilled water. 
• This mixture will form a clot in 1 to 2 minutes if the reagents are fresh 
and not too cold. Place resulting clot in a cassette that has been lined 
with lens paper to prevent the clot from oozing through the holes. 
•  This clot is very soft and a spatula, instead of a forceps, is 
recommended for transfer to the embedding mold. 
5. Compact Cell Block Technique: 
Yang et al (1998)
59
 described a technique that produces a compact cell 
block about 10% to 20% the size of conventional cell blocks. Cells are 
packed into a small area free of erythrocytes and extracellular protein, 
thereby reducing the overall time for screening and often the need for deeper 
cuts are eliminated. 
• Pour off the supernatant after centrifugation of 40 cc of a well mixed 
aliquot of the sample. 
• Mix the sediment with an equal volume of CytoRich Red. 
• After 2 minutes, add 4 drops of plasma and 3 drops of thrombin (5,000 
µl/10 ml). 
• Gently agitate the mixture. When the clotting stops, the clot is slided 
onto the lens paper placed on top of paper towels. 
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• The lens paper is folded over the clot. Press and mold the clot flat and 
compact with a gloved fingertip. Wrap the compact clot tightly in lens 
paper and place in fixative. 
6. Microwave Technique for Rapid Processing of Cell Block: 
Since the early 1970s, microwaves have been used by histopathology 
laboratories to shorten fixation and processing times of tissue samples. In 
1988, Kok et al
60
 described a method in which cell blocks from fresh sputum 
can be prepared in 35 minutes. The method can be adapted for use with other 
types of specimens.Best results were obtained with a fixative consisting of 
500 ml of 96% ethyl alcohol, 430 ml of distilled water, and 70 ml of 
polyethylene glycol. 
• Place sputum in 40 ml of fixative in a microwave-safe jar. 
• Microwave sample at 450 watts with the temperature set at 70°C. This 
usually takes 5 minutes. 
• Place the sputum, which has become condensed and rubbery, into a 
tissue cassette. Put the cassette into 40 ml of absolute ethyl alcohol 
and microwave at 450 watts and 70°C. This usually takes 3 minutes; 
however, let the cassette sit in the microwave for another 2 minutes. 
• Transfer cassette to 40 ml of Histoclear. Microwave at 450 watts or 
80°C for 7 minutes. 
• Embed the material, cool blocks, cut and mount sections. 
 41 
 
• Sections can be de-paraffinized by placing them in Histoclear and 
microwaving them for 5 minutes at 700 watts and then stained by the 
method of choice. 
7. Cell blocks from Millipore Filters: 
Baloch et al (1999)
61
 described a technique by which a portion of a 
Papanicolaoustained millipore filteris converted to a cell block for other 
stains or immunocytochemical analysis for specimens of limited 
cellularity.This technique produces hematoxylin and eosin (H&E) 
preparations with excellent morphology and antibody test results. In most 
cases, routine cell blocks with adequate background staining is not seen.The 
original cytologic preparation is preserved asonly half of the filter is used. 
8. Shidhams protocol: 
The use of cell block sections is a valuable ancillary tool for 
evaluation of non-gynecologic cytology. They enable the cytopathologist to 
study additional morphologic specimen detail including the architecture of 
the lesion. Most importantly, they allow for the evaluation of ancillary 
studies such as immunocytochemistry, in-situ hybridization tests 
(FISH/CISH) and in-situ polymerase chain reaction (PCR). Cell blocks have 
traditionally been applied to cytology of non-gynecologic specimens like 
fine needle aspiration biopsies and body fluid effusions. 
Liquid based non-gynecologic specimens have many individual 
scattered cells. When the cellularity is less, the cell block sections are 
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difficult to achieve. The histotechnologist making sections of the block 
cannot identify the level of highest concentration of cells for sectioning and 
transferring it to the glass slides for analysis. Hence the cell block area with 
maximum cells may be missed, either by not cutting deep enough or cutting 
past the region. Current Shidham protocol eliminates these drawbacks. This 
protocol is standardized and reported for non-gynecologic specimens like 
FNA, brushings, effusion fluids, cyst contents etc., for improving the quality 
of material in cell blocks. 
The following are the two critical features for preparing cell blocks from 
hypocellular specimens with scattered single loose cells by this protocol
62-66
. 
1) Step to concentrate the cells along a parallel plane to the cutting 
surface of the cell block. 
2) Dark inclusion as AV-marker,serving like a beacon for two 
purposes: 
a) To visualize the site of cellular concentration, as dark colored 
beacon, exposed during cutting. The ability to identify a dark 
colored beaconprevents from cutting through the+ 8 level with most 
cells or not cutting too superficial into the level of highest 
concentration of cells. 
b) To serve as a locator reference point in serial cell block section on 
different slides. The beacon helps to locate particular cells or groups 
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of cells for assessment of a coordinate immunoreactivity pattern 
with the SCIP approach
67,68
. 
Protocol- 
Sample Preparation: 
1) The residual liquid based cytology (LBC) specimen is transferred to a 
flat bottomed glass tube (15mm diameter x 45mm). The glass tube is 
placed in a larger plastic carrier tube (28 x 85mm) for centrifugation. 
The glass bottomed tube is removed from the carrier tube and the 
supernatant is poured off. 
2) The glass tube is capped (to prevent spillage of heating water in the 
next step) and placed inside acarrier plastic tube which is larger and 
flat bottomed. 
3) The carrier plastic tube with the glass tube is then capped and placed 
for centrifugation (with swiveling cups and not fixed angle cups so 
that the cells fall perpendicularly to the flat bottom of the glass tube) 
at 1805 G (3000 rpms, rotor radius- 17cm) for five minutes. 
4) The tubes are removedfrom the centrifuge vertically and the smaller 
glass tube is removed with forceps from the larger carrier plastic tube 
avoiding any disturbance to the sedimented pellet of cells. 
5) The glass tube with specimen is uncapped and the supernatant is 
poured off without disturbing the flat layer of cells, sedimented at the 
bottom. 
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Inclusion of the reference coordinates, AV-marker and addition of gel: 
1. A dark beacon AV-marker (about 2 mm X 2 mm size, flat surfaced, 
fragment of dark colored, sectionable material) which is added, acts as 
a signpost in the glass tube. 
2. An aliquot of histogel (HG) is liquefied by melting it in a microwaveat 
medium power for 10 seconds. 
3. 0.5 ml of molten HG is added to the tube and mixed with the sediment 
quickly and recapped (Proceed to the next step quickly without 
allowing the HG to begin solidifying). 
4. 2.5 ml of warm (45° C) water is added to the carrier plastic tube. 
5. The smaller capped glass tube is placed inside the plastic tube with 
warm water. (This step is necessary to keep the HG from solidifying 
during the next steps). 
6. The carrier plastic tube is placed for centrifugation (with swiveling 
cups and not fixed angle cups so that the cells fall perpendicularly to 
the flat bottom of the glass tube), for five minutes at 1805 G (3000 
rpms, rotor radius- 17cm). The centrifugation pushes the AV-marker 
and concentrates the cellsof the final paraffin embedded cell block into 
a layer closer to the cutting surface. 
7. The tubes are removed vertically and gently from the centrifuge 
avoiding disturbance to the sedimented thin layer of cells at the 
bottom. 
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8. The larger plastic tube is uncapped and the smaller glass tube is 
removed vertically with a forceps without disturbing the sedimented 
layer of cells. 
9. The small glass tube is refrigeratedfor 15 minutes in vertical position, 
to cool and solidify the HG. 
Removal of the cell block as a button of gel with specimen for final 
processing: 
1) The solidified HG disk, with the layer of concentrated/sediment 
specimen at the bottom is dislodged from the flat bottom glass tube by 
squirting 10% formalin through a 23 gauge needle with the syringe. 
2) The needle is inserted along the side of the tube at the periphery of 
solidified HG disc with specimen. 
3) The needle is rotated along the side of the tube while formalin is being 
slowly pushed in through the syringe. This results in the separation of 
the HG button along with dark colored beacon AV-marker and the 
concentrated specimen in it, from the flat bottom of the glass tube. 
4) The cell block (gel button with specimen cells) is then placed in a 
labeled cassette and submitted for tissue processing to prepare paraffin 
embedded cell blocks. 
Embedding and cutting of the specimen: 
1. The disk is embedded in paraffin with the dark beacon marker side 
down as cutting surface. 
 46 
 
2. The block is sectioned until the dark colored AV-marker as a beacon is 
exposed and clearly visible. 
3. Three to four micron sections are cut from this level which should 
contain most of the singly scattered cells from the specimen. 
4. The sections are collected on the glass slide for further staining, 
immunohistochemical staining or other tests as indicated. Generally 
for immunostaining, coated slides are used to prevent floating and loss 
of sections from the slides during the immunostaining steps. 
9. Modified cell block technique: 
Nathan et al in 2000 suggested a modified cell block technique by 
using Nathan alcohol formalin substitute (NAFS)
69
. After preparing smears, 
the needles and syringes utilized for fine-needle aspirates were rinsed in 10 
mL of 50% ethanol in a specimen container. Any residual clot or tissue in 
the hub of needles was removed carefully in the laboratory with the aid of 
another needle and rinsed in 50% ethanol. At 4,000 rpm for 6 minutes,the 
material was centrifuged in a 10-mL centrifuge tube to create one or more 
cell pellets. The supernatant fluid is decanted and the deposit fixed in freshly 
prepared Nathan alcohol formalin substitute (NAFS) consisting of 9 parts of 
100% ethanol and 1 part of 40% formaldehyde. Since formalin oxidises to 
formic acid on exposure to air, forming acid hematin pigment artifacts, 
afresh working solution is desired. 
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 Centrifuged deposits of effusions, clots, washings, and other fluids, 
following smear preparations, were fixed similarly for cell blocking. When 
centrifuged deposits were more than 0.2 mL thick, to facilitate adequate 
fixation, the deposit was detached carefully from the bottom of the 
centrifuge tube with the aid of a sharp-edged dipstick. If the centrifuged 
deposits were too thick, the material was divided into several tubes for 
multiple cell blocks before fixing in NAFS solution. The fixed cell pellets, at 
the end of fixation for 45 minutes, were re-centrifuged for 6 minutes at 4,000 
rpm. These pellets should detach themselves or can be removed easily with a 
disposable Pasteur pipette following centrifugation. After wrapping the cell 
pellets in crayon paper and placing in a cassette it is stored in 80% ethanol 
until ready for processing in the automatic tissue processor. 
10. Thromboplastin Plasma Cell Block (TP-CB) technique: 
Kulkarni et al in 2009 used plasma thromboplastin for preparing cell 
block
70
.After preparing conventional smears, the remaining fluid were 
centrifuged.In the case of aspirations, rinses of syringes and needles were 
centrifuged by collecting it in normal saline.The supernatant was carefully 
removed and the sedimentwas mixed with two drops of pooled plasma that 
was kept frozen and brought to room temperature before use.Subsequently, 
four drops of thromboplastin were added and mixed again. The 
thromboplastin used for the TP-CB was the same as the one used for the 
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thromboplastin test and it should be stored in the refrigerator between 2-8 C◦ 
and brought to room temperature before use.The tube was allowed to stand 
for 5 min. and the resultant clot was slid into a filter paper pre-moistened 
with formalin, wrapped and put in a cassette. The tissue cassette was then 
fixed in buffered formalin for at least 4 hrs. After-wards, the sample was 
processed as usual for histological techniques. 
Principle antibodies currently used in diagnosis of lung and pleural 
tumor’s- 
Diagnosis and classification of lung and pleural neoplasms are 
complex due to diverse histopathology and tumor heterogeneity. A wide 
variety of primary neoplasms occur in the lung.Four major types make up 
85% to 90% of primarylung neoplasms: adenocarcinoma, squamous cell 
carcinoma, small cell carcinoma, and large-cell undifferentiatedcarcinoma
71
. 
 Evaluation of pulmonary and pleural neoplasms requires 
determination of histopathologic type and differentiation, as well as 
assessment of probable site of origin. This process is currently based 
primarily on histopathologic features, immunohistochemistry (IHC) provides 
valuable additional information in several settings. 
 First, IHC can assist in diagnosis and classification of a neoplasm as a 
non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC), a 
distinction critically important for determining therapy.  
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Second, IHC can provide evidence to support the interpretation of a 
neoplasm with neuroendocrine differentiation. And finally, IHC can help the 
differential diagnosis between lung carcinomas and malignant 
mesotheliomas, between lung carcinomas and metastatic extra-pulmonary 
malignancies. 
 In the last decade, a broad spectrum of antibodies or 
immunohistochemical markers have been developed and used to resolve 
these differential diagnostic questions.  A large number of 
immunohistochemical markers have recently become available to facilitate 
accurate diagnosis and classification of pulmonary and pleural neoplasms. 
Most important generic immunomarkers of lung carcinomas are the 
following: 
Cytokeratin 7 and cytokeratin 20: 
Cytokeratin7 is a 54-kDa marker of simple epithelium found in the 
columnar and glandular epithelium of lung. In pulmonary pathology, 
antibodies to CK7/CK20 are most helpful in the differential diagnosis of 
pulmonary adenocarcinoma and metastatic colonic adenocarcinoma. Most 
lung adenocarcinoma are CK 7+/ CK 20-, while most metastatic colon 
adenocarcinoma in lung are CK 7-/ CK 20+
72
. 
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Cytokeratin 5/6: 
Cytokeratin 5 and 6 are high molecular weight, basic cytokeratins 
which correspond to keratins 58 and 56 kDa respectively. Cytokeratin 5/6 is 
most commonly used in the diagnosis of mesothelioma, where it stains 
tumour cellsand reactive mesothelium in a diffuse cytoplasmic fashion
73
. 
Most pulmonary adenocarcinomas do not express CK 5/6, although one 
study showed that 19% of them had weak or focal positive staining
74
. 
Antibodies to CK5/6 are best used in a panel of antibodies for the differential 
diagnosis of mesothelioma and pulmonary adenocarcinoma. 
Calretinin: 
Calretinin is a calcium binding protein with a molecular weight of 
29kDa. Calretinin is consistently expressed in the normal and reactive 
mesothelial cell lining of serosal membranes. It stains in diffuse nuclear/ 
cytoplasmic pattern in formalin fixed paraffin embedded tissue sections. It is 
probably the most specific marker for mesothelial cells. The presence of 
calretinin is also a sensitive and specific indicator of normal and reactive 
mesothelial cells in effusion cytology. Anti calretinin antibody is a useful 
marker to distinguish mesothelioma from adenocarcinoma. 
HBME-1: 
HBME-1 was derived from human malignant epithelioid 
mesothelioma cells. It consists of antigens on the cell membrane of 
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mesothelial cells, both benign and malignant. So it shows membranous cell 
surface pattern in epithelioid mesotheliomas, while it is negative or shows 
cytoplasmic staining in adenocarcinoma. Its usefulness is limited by its low 
specificity.  
Ber-EP4: 
 Antibody to Ber-EP4 shows a broad pattern of reactivity with human 
epithelial tissues, from simple epithelia to basal layers of stratified, non-
keratinized squamous epithelium and epidermis. The staining pattern is 
membranous and used to distinguish adenocarcinoma from mesothelioma.it 
has very high sensitivity (94 – 100%) for lung adenocarcinomas, it also 
stains 9-18% of epithelioid mesotheliomas
75
. So the interpretation of staining 
result should always be done in combination with other antibodies. 
B72.3: 
The mouse monoclonal antibody to B72.3 recognizes a high molecular 
weight glycoprotein complex, TAG 72(tumor associated glycoprotein -72). 
This antibody works on formalin fixed, paraffin embedded tissues and cell 
blocks prepared from body fluids. It can be used in an antibody panel to 
distinguish adenocarcinomas from mesotheliomas. It has been shown to be 
positive in about 90% of pulmonary adenocarcinomas and in 0-14% of 
mesotheliomas
76
. 
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Thyroid transcription factor -1(TTF-1): 
Human TTF-1 is a single polypeptide of 371 aminoacids. It is 
expressed at the onset of lung and thyroid organogenesis and is essential for 
the normal development of these organs
77
. It is expressed in thyroid 
follicular epithelial cells, pulmonary type-II cells and clara cells which 
makes it a useful diagnostic epitope to identify adenocarcinomas. It is a 
useful marker in differential diagnosis of primary tumors of lung and thyroid 
versus metastases from other organs. It shows a nuclear staining pattern. 
TTF-1 is expressed in 90% of small cell carcinomas of the lung, 80-90% of 
pulmonary carcinoids and 70-100% of adenocarcinomas of lung. 
Surfactant apoproteins A and B: 
Antibodies to pulmonary epithelial cell specific surfactant 
apoproteins-A (SP-A) and B(SP-B) have been used to differentiate primary 
lung non-small cell carcinoma (in particular, adenocarcinoma) from extra 
pulmonary neoplasms. This stains about 50- 60% of both non-small cell 
carcinomas and adenocarcinoma of the lung
78
.    
NAPSIN A: 
Napsin A is an aspartic proteinase involved in the maturation of 
surfactant protein-B. It is detected in the cytoplasm of type II pneumocytes 
and alveolar macrophages. It is a highly sensitive marker for pulmonary 
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adenocarcinomas (positive in about 80% of cases), and thus is a useful 
alternative of TTF-1
79
. 
ES1: 
This antibody, which recognizes a variant form of CEA-related cell 
adhesion molecule-6, has been touted as a marker which stains selectively 
lung carcinoma in a more sensitive fashion than TTF-1. Obviously, this 
claim will need to be proven independently
80
. 
P63: 
 A study demonstrated by immunohistochemical methods showed that 
p53, p63, p73 expression are gradually increased in dysplastic squamous 
cells epithelium. Of these markers, p63 is of  greatest potential interest as a 
marker for squamous cell carcinoma. This epitope is expressed in pulmonary 
epithelium and pulmonary squamous cell carcinoma, 95-100% of which 
show nuclear staining. 
Immunohistochemical staining pattern in major histological subtypes of 
lung and pleural tumor’s: 
Squamous cell carcinoma: 
Squamous cell carcinomas are immunoreactive to most epithelial 
markers, such as pancytokeratin, low molecular weight keratins, high 
molecular weight keratins and focally epithelial membrane antigen 
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(EMA).Some rare variants of squamous cell carcinoma that cause difficulties 
in diagnosis are papillary, clear cell, small cell and basaloid forms. 
Staining with p63 and TTF-1 was shown to be helpful in 
differentiating small cell carcinoma from poorly differentiated squamous cell 
carcinoma
81
. Small cell carcinomas were negative for p63 and 87% of them 
were positive for TTF-1, whereas all poorly differentiated squamous cell 
carcinoma were positive for p63 and negative for TTF-1. 
Adenocarcinoma: 
Adenocarcinomas express low molecular weight keratin, in particular 
pulmonary adenocarcinomas are usually cytokeratin-7 positive and 
cytokeratin-20 negative except for bronchoalveolar carcinoma
82
. When high 
molecular weight keratins are present, the tumour may have a mixed 
adenosquamous phenotype. It also expresses EMA, CEA, Ber-EP4. In 
current practice, the most commonly used antibody to identify an 
adenocarcinoma as primary in lung is TTF-1(72- 96%)
83
. 
Bronchioloalveolar carcinoma: 
The diagnosis of bronchioloalveolar carcinoma usually does not 
require immunohistochemical study because of its distinct alveolar growth 
pattern. Well differentiated mucinous or goblet cell bronchioloalveolar 
carcinomas, infrequently (0-20%) expresses TTF-1
82
. Nearly 90% of well 
differentiated mucinous bronchioloalveolar carcinomas express CK20. This 
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atypical immunohistochemical staining pattern can make the differential 
diagnosis with metastatic adenocarcinoma of colon difficult. 
Small cell carcinoma: 
Immunohistochemical stains are helpful to establish the diagnosis of 
small cell carcinoma, particularly in minute or crushed samples. It stains 
with antibodies to keratin, this is of great help to separate them from 
lymphoid cells and lymphomas. A classic finding is punctate cytoplasmic 
staining for keratin, but it is seen in only about 40% of cases. The most 
useful neuroendocrine markers for diagnosis are chromogranin-A and 
synaptophysin. Lyda and weiss et al
84
, showed that 84% of small cell 
carcinomas stained for chromogranin-A and 58%stained for synaptophysin. 
Negative staining for neuroendocrine markers does not exclude the diagnosis 
of small cell carcinoma. 
A variety of other markers reported in small cell carcinomas are CD56 
or N-CAM, histidine decarboxylase, EMA, bombesin, gastrin releasing 
peptide and class III beta- tubulin
85
. CD-56 shows high percentage (94- 
100%) of small cell lung carcinomas. Tumour cells stain in a strong 
membranous pattern in the paraffin sections. 
Large cell carcinoma: 
All the large cell carcinoma stains for pancytokeratin and low and 
high molecular weight cytokeratin due to the epithelial nature of the 
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neoplasm. Vimentin is co-expressed in these tumors and almost negative for 
TTF-1
86
. Basaloidcarcinoma, a histological variant of large cell carcinoma 
preferentially expresses high molecular weight keratin (CK 5/6 and 14) but 
not lower molecular weight keratin. This variant can be differentiated from 
large cell neuroendocrine carcinoma as the later shows positivity for 
neuroendocrine markers. 
Metastatic renal cell carcinoma is an important differential diagnosis 
for clear cell carcinoma variant of large cell carcinoma .This can be 
differentiated by the expression of CD-10 by most of the renal cell 
carcinoma. 
In Large cell neuroendocrine carcinoma, the neoplastic cells are 
positive for neuroendocrine markers in a very patchy and weak pattern. The 
tumour cells also stain for keratin and CEA (100% each). 
Adenosquamouscarcinoma: 
There is no specific immunohistochemical marker for adenosquamous 
carcinoma. It expresses the antigens found in adenocarcinoma and squamous 
cell carcinoma of lung.The glandular component of the tumor is usually 
TTF-1 positive
86
. 
Sarcomatoid carcinoma: 
This tumour refers to poorly differentiated non-small cell carcinomas 
that show marked variation in cell shape or size or that have a component of 
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sarcomatous or sarcoma like differentiation. Pleomorphic carcinoma is 
positive for cytokeratins in 75-100% of cases.EMA, CEA OR Ber –EP4 can 
also be present
87
. 
In spindle cell carcinoma, immunohistochemical detection of 
cytokeratin, CEA, EMA or other epithelial antigens in the spindle cells is 
required for the diagnosis. Keratin or epithelial membrane antigen is present, 
along with CEA and vimentin. In carcinosarcoma, the epithelial component 
stains positive for keratin (100%) and the stromal component shows 
positivity for S-100, desmin, actin, myoglobin based on the differentiation of 
the sarcomatous component. 
Typical and atypical carcinoids: 
Carcinoids express neuroendocrine cell markers, particularly 
chromogranin followed by synaptophysin and leu-7. These markers stain 
more intensely and diffusely than do other neuroendocrine tumors.Atypical 
carcinoids show slightly less extensive and intensive staining for these 
neuroendocrine markers than do carcinoids.TTF-1 can be used to distinguish 
pulmonary carcinoids and their metastases from metastatic intestinal and 
pancreatic carcinoids. 
Carcinomas of salivary gland type: 
Mucoepidermoid carcinoma rarely requires immunohistochemical 
staining for diagnosis. The tumour cells are immunoreactive for 
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pancytokeratin, mucicarmine or mucin stains for mucin containing cells and 
few cases show reactivity for CK7 and CA19-9.Adenoid cystic carcinoma 
shows strong epithelial reactivity for low molecular weight keratins, 
vimentins. 
In Pleomorphic adenoma the epithelial component shows strong 
staining for low molecular weight keratins. The basal layer of ductular cells 
and many of the spindle and stellate cells lie in the myxoid matrix and stain 
for vimentin. 
Malignant mesothelioma: 
Immunohistochemistry places an important role in the differentiation 
between malignant epitheliod mesothelioma and adenocarcinoma. 
Mesothelial markers include calretinin, CK-5/6, WT-1, thrombomodulin, 
HMBE-1 and mesothelin. Adenocarcinoma markers include CEA, leu–M1, 
Ber-EP4, MOC-31, B72.3, TTF-1 and BG8. There is considerable variability 
in sensitivity and specificity of these markers. 
Calretinin is highly sensitive marker for mesothelial lineage. It is 
present both in the cytoplasm and the nucleus of the mesothelial cells. 
Nuclear staining must be present for the diagnosis. The antibody stains 50-
100% of the mesotheliomas but 0-70% of the adenocarcinomas. 
CK-5/6 is highly sensitive and specific mesothelioma marker, staining 
in a cytoplasmic pattern. This marker is 55-100% of mesotheliomas and in 0-
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21%in the adenocarcinomas. It can also be seen in squamous cell and 
transitional carcinoma. 
Wilms tumour gene product (WT-1) is a nuclear protein expressed in 
the mesothelial cells. Nuclear staining is seen in 71-95% of malignant 
mesotheliomas and 0-22% in adenocarcinoma. 
Thrombomodulin (CD 141) is less sensitive and specific than other 
markers. It shows membranous staining in 30-100% of the epithelial 
mesotheliomas and in 5-77% of adenocarcinoma. 
HMBE-1 consists of antigens from the cell membrane of mesothelial 
cells. The antibody stains 57-100% of mesotheliomas. 
TTF-1, a nuclear transcription factor is found in the adenocarcinoma 
originating from lung and thyroid. It is commonly expressed in the nuclei of 
75% of adenocarcinoma of lung and 25% of the large cell carcinomas of the 
lung, but not in the mesotheliomas. 
Carcinoembryonic antigen(CEA) is most sensitive and frequently 
positive marker in the adenocarcinoma of the lung and gastrointestinal tract. 
The staining pattern is cytoplasmic. Adenocarcinomas stain frequently (60-
100%) and mesothelioma infrequently(0-21%). 
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MATERIALS AND METHODS 
During the period from January 2013 to August 2014, 100 samples 
from minimally invasive procedures of pulmonary lesions (pleural fluid, 
bronchial washings, remnants of fine needle aspiration cytology) sent to the 
Department of Pathology, Tirunelveli Medical College and hospital were 
analyzed by conventional cytology smear study and cell block technique. 
Immunohistochemical staining was done for cases which were reported as 
malignant or suspicious for malignancy. 
Clinical information of patients regarding age, sex and clinical 
diagnosis were recorded. Most sample fluid was processed immediately, but 
in small number of samples, when there is a delay the specimens were stored 
in refrigerator and processed later. 
After receiving the samples of pleural fluid and bronchial washing, 
clots if present, were removed with a spatula by pressing the clot against the 
sides of the container and clot was cut into small fragments and was fixed in 
10% buffered formalin.The fluid was divided in to two parts. One part of the 
fluid was taken and centrifuged at 2500rpm for 15 minutes and the sediment 
was smeared on a glass slide. The smears were fixed in 99.9% isopropyl 
alcohol for 20 minutes andwere stained with haematoxylin and eosin. The 
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other part was used for making cell block using plasma thromboplastin 
method described below. 
Fine needle aspiration mostly percutaneous was done by multiple 
passes with 23G needle and the smears were made on a glass slide and 
stained with haematoxylin and eosin. Samples collected for the cell block 
were either from an additional dedicated needle aspiration and or needle 
rinse of the existing needle passes.The residual fine needle aspiration 
cytology material taken by rinsing the syringe and hub of the needle with 
10% neutral buffered formalin and cell blocks were made as described 
below. 
Cell block preparation: 
The samples of pleural fluid, bronchial wash and FNAC remnants 
were centrifuged at 2500rpm for 15 minutes. After centrifuging, supernatant 
was carefully removed and discarded and the sediment was mixed with two 
drops of plasma that was kept frozen and brought to room temperature 
before use. If any clots were present in the sample, it was removed and 
processed as a routine histopathological specimen. In case of FNAC 
remnants, the rinses of syringes and needles were washed with normal saline 
before plasma is added. 
Immediately, four drops of thromboplastin was added and mixed well. 
The thromboplastin was stored in refrigerator between 2 and 8°c and brought 
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to room temperature before use. The mixture was left undisturbed for few 
minutes until a clot was formed. If there was no clot formation, four more 
drops of thromboplastin was added until clot appeared. Then the clot was 
scooped out onto a filter paper and placed in a cassette. The tissue cassette 
was then fixed in 10% neutral buffered formalin for atleast 4 hrs. Afterwards 
it was processed along with routine histopathological specimens. 
Cell blocks were made and tissue sections of 4-5 micron thickness 
were taken and stained with hematoxylin and eosin. Subsequently, these cell 
blocks were used to do immunohistochemistry whenever needed. 
Procedure for immunohistochemistry: 
1) From the selected cell blocks 3-4µm thickness sections were taken 
in a poly- lysine coated adhesive slides. The slides were incubated 
at 45°c for one hour. 
2) Slides are then subjected to 2 changes of xylene for 5 minutes each 
for de-paraffinization. Then the slides are transferred to absolute 
alcohol for 5 minutes which is then followed by 80% and 70% 
alcohol for 5 minutes each to rehydrate the sections. 
3) Sections are then placed in running tap water for 5 minutes and 
washed in distilled water. 
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4) Antigen retrieval was performed using pressure cooker in TRIS- 
EDTA buffer or citrate buffer depending on the primary antibody 
used. Sections are cooled and slides are washed in distilled water. 
5) Endogenous peroxidase activity is removed by incubating the 
sections with enough drops of 3% peroxide block in a humidity 
chamber. Then the sections are washed in washed buffer. Then 
protein block is added for 20 minutes. 
6) Primary antibody is then added to the section and incubated for 30 
minutes, followed by that primary amplifier is added for 20 
minutes and the sections are washed in wash buffer. 
7) DAB chromogen (1ml DAB buffer + 1 drop of DAB chromogen) 
is then added over the section and incubated for 4 minutes and then 
washed with two changes of distilled water. 
8) Counterstaining was done with Mayer’s hematoxylin for 30 
seconds and washed in running tap water. 
9) Dehydration is done by 2 changes of 100% alcohol. Mounting is 
done by DPX mountant and observed under microscope. 
Buffer preparation: 
TRIS- EDTA buffer (pH 9.0): 
TRIS – 6.05gm 
EDTA – 0.744gm 
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Distilled water – 1000ml 
TRIS wash buffer: 
TRIS – 0.605gm 
Sodium chloride – 8gm 
1N Hcl – 4ml 
Distilled water – 1000 ml. 
Citrate buffer: 
Citrate -1.92gm 
Distilled water – 1000ml 
Precautions: 
1. All the buffers used should be prepared fresh and the Ph should be 
adjusted according to the preferred pH. 
2. Humidity chamber should always be used to prevent drying during 
the staining procedure. 
3. DAB chromogen should be handled and disposed carefully as it is a 
carcinogen. 
4. Primary antibody and all the reagents used in the 
immunohistochemistry procedure should be stored in 4- 6°c 
5. Glass wares used should be dry and clean. 
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Interpretation of conventional smears and cell block: 
A comparison between the cellularity, morphologicalpreservation, 
architectural preservation and background was performed on both 
conventional smear and cell block based on the point scoring system 
described by Mair et al
68
. 
Criterion Qualitative description Point score 
1)Volume of 
obscuringbackground blood 
or proteinaceous material 
Large amount: Diagnosis greatly 
compromised 
0 
Moderate amount: Diagnosis possible 1 
Minimal amount: Diagnosis easy 2 
2)Amount of 
diagnosticcellular material 
present 
Minimal or absent: Diagnosis not possible 0 
Sufficient for cytodiagnosis 1 
Abundant : Diagnosis simple 2 
3) Degree of 
cellulardegeneration and 
cellular trauma. 
Marked: Diagnosis impossible 0 
Moderate: Diagnosis possible 1 
Minimal: good preservation 2 
4)Retention of 
appropriatearchitecture and 
cellular arrangement 
Minimal to absent: non-diagnostic 0 
Moderate: some preservation eg: follicles, 
papillae,acini, synctia or single cell pattern. 
1 
Excellent architectural display, closely 
reflectinghistology: diagnosis obvious 
2 
According to the criteria mentioned above, comments were rendered 
on the quality of the slides by qualitatively grouping them into three 
categories: 
1) Diagnostically unsuitable (score 0-2) 
2) Diagnostically adequate (score 3-6) 
3) Diagnostically superior (score 7-8) 
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The conventional smears and cell block were reported under the 
diagnostic category as benign, suspicious, malignant and non-
diagnostic.Combined evaluation of conventional smear and cell block was 
done and tabulation of cytomorphological characters was analyzed. 
INCLUSION CRITERIA: 
All samples of Pleural effusion, bronchial washings and guided fine 
needle aspiration cytology of lung masses received in clinical pathology. 
EXCLUSION CRITERIA: 
1) Samples processed after 48hrs 
2) All other fluid specimens except pleural fluid and bronchial 
washings. 
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TABLE 6: COMPARISON OF DIAGNOSIS IN PLEURAL EFFUSION 
DIAGNOSIS 
CONVENTIONAL 
SMEAR 
CELL 
BLOCK 
INFERENCE 
Benign 36 40 
Pearson Chi-
square 
0.000 
 
Suspicious 3 0 
Malignant 4 6 
Non-diagnostic 7 4 
By conventional smear the definite diagnosis of benign nature of 
pleural effusion was made in 36 cases (72%), malignant nature was made in 
4 cases (8%). Suspicion of malignancy in effusion was made out in 3 cases 
(6%) and smear was non-diagnostic in 7 cases (14%). 
In cell block, the benign nature was well defined in 40 cases (80%), 
malignant in 6 cases (12%), non-diagnostic in 4 cases (8%) and none was 
still suspicious (From TABLE 6 & FIG 7). 
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PRIMARY SITES OF MALIGNANT PLEURAL EFFUSION: 
In conventional smear, 4 malignant effusions were diagnosed which 
includes 1 case of breast malignancy, 1 from ovarian malignancy and 2 cases 
of metastatic adenocarcinoma. 
 By cell block, 6 malignant effusions were reported. Primary was 
already known for 3 cases which include 1 case of ovarian malignancy, 2 
cases of breast malignancy. In 3 cases features were suggestive of 
adenocarcinoma which was further evaluated by immunohistochemistry. 
II.ANALYSIS OF BRONCHIAL WASH SPECIMENS: 
TABLE 7.AGE DISTRIBUTION: 
AGE MALE FEMALE TOTAL 
20-30 5 0 5 
31-40 0 0 0 
41-50 5 1 6 
51-60 7 2 9 
61-70 10 2 12 
>70 3 0 3 
TOTAL 30 5 35 
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TABLE 11:COMPARISON OF DIAGNOSIS IN BRONCHIAL WASH: 
DIAGNOSIS 
CONVENTIONAL 
SMEAR 
CELL BLOCK INFERENCE 
Benign 23 26 
Pearson Chi-
square 
0.000 
 
Suspicious 2 0 
Malignant 7 9 
Non-diagnostic 3 0 
By conventional smear the definite diagnosis of benign nature of 
bronchial wash was made in 23 cases (65.71%), malignant in 7 cases (20%). 
Suspicion of malignancy in bronchial wash was made out in 2 cases (5.71%) 
and smear was non-diagnostic in 3 cases (8.57%). 
 In cell block, the benign nature was well defined in 26 cases 
(74.28%), malignant in 9 cases (25.71%), non-diagnostic and suspicious in 
none (FromTABLE 11 & FIG 12). 
 
23
26
2
0
7
9
3
0
0 5 10 15 20 25 30
CONVENTIONAL 
SMEAR
CELL BLOCK
FIG 12:COMARISON OF DIAGNOSIS BY CS & CB IN 
BRONCHIAL WASH
NONDIAGNOTIC
MALIGNANT
SUSPICIOUS
BENIGN
  
TABLE 12: MALIGNA
CELL BLOCK IN BRON
SUBTYPING OF 
MALIGNANCY 
Squamous cell carcinom
Adenocarcinoma 
Small cell carcinoma
Large cell carcinoma
TOTAL 
In conventional sm
case of adenocarcinoma w
By cell block techni
of adenocarcinoma were d
 
1
FIG 13:SUBT
80 
NCY BY CONVENTIONAL SMEA
CHIAL WASH: 
CONVENTIONAL     
SMEAR 
CELL
a 6 
1 
 0 
 0 
7 
ear, 6 cases of squamous cell carcinom
as diagnosed. 
que, 8 cases of squamous cell carcinoma
iagnosed (From TABLE 12 & FIG 13).
 
8
YPING OF MALIGNANCY BY CELLBLOC
BRONCHIAL WASH
SQUAMOUS CEL
CARCINOMA
ADENOCARCIN
R AND 
 BLOCK 
8 
1 
0 
0 
9 
a and one 
, one case 
 
 
K IN 
L 
OMA
  
III.ANALYSIS OF FN
TABLE 13: AGE DISTR
AGE 
20-30 
31-40 
41-50 
s51-60 
61-70 
>70 
TOTAL 
Maximum numbers
which accounts for 40% o
the age group of 61-70 ye
(From TABLE 13 & FIG 1
 
0
1
2
3
4
5
6
20-30 31-40
0
1
1
0
FIG 14:A
81 
AC SPECIMENS 
IBUTION: 
MALE FEMALE 
0 1 
1 0 
4 0 
2 0 
6 0 
1 0 
14 1 
 of samples were in the age group of 61
f the FNAC samples. Males were predom
ars and females in the age group of 20
4). 
 
41-50 51-60 61-70 >70
4
2
6
1
0
0
0
0
GE DISTRIBUTION IN FNAC SAMPLES
TOTAL 
1 
1 
4 
2 
6 
1 
15 
-70 years, 
inantly in 
-30 years 
 
FEMALE
MALE
  
TABLE 14:COMPARISI
BLOCK IN FNAC: 
QUALITY 
CONVE
SM
Unsuitable 
Adequate 
Superior 
 
The quality of smea
(6.66%), adequate in 14 ca
In cell block, 1(6.6
adequate and 6 (40%) case
 
0%
CONVENTIONAL 
SMEAR
CELLBLOCK
1
1
FIG 15:COMP
82 
ON OF QUALITY OF SMEAR& CE
NTIONAL 
EAR 
CELL 
BLOCK 
INFER
1 1 
Pears
squ
0.
14 8 
0 6 
r analyzed conventionally was unsuitable
ses (93.33%) and superior in none.  
6%) case was unsuitable, 8 cases (53.3
s were superior (From TABLE 14 & FIG
 
50% 100%
14
8
0
6
ARISION OF QUALITY OF CS & CB  IN F
UNSU
ADEQ
SUPE
LL 
ENCE 
on chi 
are 
001 
 in 1 case 
3%) were 
 15). 
 
NAC
ITABLE
UATE
RIOR
  
TABLE 15: COMPARIS
CELLULARITY 
CONV
Minimal 
Sufficient 
Abundant 
 
The cellularity dete
cellularity in 3 cases (20
abundant cellularity in non
 The cellularit
sufficient in 9 cases (60%
& FIG 16). 
 
0%
CONVENTIONAL 
SMEAR
CELL BLOCK
3
3
FIG 16:COMPA
83 
ON OF CELLULARITY IN FNAC: 
ENTIONAL 
SMEAR 
CELL 
BLOCK 
INFER
3 3 
Pears
sq
0.
12 9 
0 3 
rmined by in conventional smear showe
%), sufficient cellularity in 12 cases (
e. 
y in cell block were minimal in 3 cas
) and abundant in 3 cases (20%) (From T
 
50% 100%
12
9
0
3
RISION OF CELLULARITY IN CS & CB  I
MI
SU
AB
ENCE 
on chi 
uare 
574 
d minimal 
80%) and 
es (20%), 
ABLE 15 
 
N FNAC
NIMAL
FFICIENT
UNDANT
  
TABLE 16: COMPARIS
ARCHITECTURE 
CO
Minimal 
Moderate 
Excellent 
The architecture an
scant cells in 3 cases (20%
clusters) in 13 cases (73.33
Whereas, the archi
scant cells in 2 cases (13
balls, clusters) in 8 cases (
5 cases (33.33%).(From TA
 
0%
CONVENTIONAL SMEAR
CELL BLOCK
FIG 17: COMPAR
84 
ON OF ARCHITECTURE IN FNAC
NVENTIONAL 
SMEAR 
CELL 
BLOCK 
INF
3 2 
11 8 
1 5 
alysis in conventional smear showed 
), cellular arrangement (acini, papillae, 
%) and excellent in none. 
tecture analysis in cell block showed 
.33%), cellular arrangement (acini, pap
53.33%) and excellent resemblance to hi
BLE 16 & FIG 17). 
 
20% 40% 60% 80% 100%
3
2
11
8
1
5
ISION OF ARCHITECTURE IN CS & CB  
FNAC
MINI
MOD
EXCE
: 
ERENCE 
Pearson chi 
square 
0.026 
 
scattered/ 
cell balls, 
scattered/ 
illae, cell 
stology in 
 
IN 
MAL
ERATE
LLENT
 85 
 
TABLE 17: COMPARISON OF DIAGNOSIS IN FNAC: 
DIAGNOSIS 
CONVENTIONAL 
SMEAR 
CELL 
BLOCK 
INFERENCE 
Benign 7 5 
Pearson Chi-
square 
0.001 
 
Suspicious 3 0 
Malignant 4 9 
Non-diagnostic 1 1 
By conventional smear the definite diagnosis of benign nature of 
FNAC was made in 7 cases (46.66%), malignant nature was made in 4 cases 
(26.66%). Suspicion of malignancy in FNAC was made out in 3 cases (20%) 
and smear was non-diagnostic in 1 case (6.66%).In cell block, the benign 
nature was well defined in 5 cases (33.33%), malignant nature in 9 cases 
(60%), suspicious in none and inconclusive in 1 case (6.66%) (From TABLE 
17 & FIG 18). 
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IV.OVERALL ANALYSIS OF CONVENTIONAL SMEAR AND 
CELL BLOCK: 
TABLE 20: OVERALL COMPARISON OF QUALITY OF SMEAR 
AND CELL BLOCK: 
QUALITY 
CONVENTIONAL 
SMEAR 
CELL BLOCK INFERENCE 
unsuitable 14 5 
Pearson Chi-
square 
0.000 
Adequate 83 67 
superior 3 28 
In the analysis of 100 conventional smears using point scoring system 
of Mair et al, 3 cases were diagnostically superior, 83 cases were adequate 
for diagnosis and 14 cases were inadequate. 
Whereas by cell block, 28 cases were diagnostically superior 
equivalent to histopathology sections, 67 cases were adequate for diagnosis 
and 5 cases were inadequate in nature (From TABLE 20 & FIG 21). 
 
14
5
83
67
3
28
0
10
20
30
40
50
60
70
80
90
CONVENTIONAL SMEAR CELL BLOCK
FIG 21:OVERALL COMPARISON OF QUALITY OF CS 
& CB
UNSUITABLE
ADEQUATE
SUPERIOR
 89 
 
TABLE 21: CELLULARITY OF CONVENTIONAL SMEAR AND 
CELL BLOCK: 
CELLULARITY 
CONVENTIONAL 
SMEAR 
CELL BLOCK INFERENCE 
Minimal 18 8 
Pearson Chi-
square 
0.000 
Sufficient 72 61 
Abundant 10 31 
 
 
In the overall analysis of 100 cases of conventional smear, 10 cases 
had abundant cellularity, 72 cases had sufficient cellularity and 18 cases had 
minimal cellularity. 
Whereas by cell block, 31 cases had abundant cellularity, 61 cases had 
sufficient cellularity and 8 cases had minimal cellularity (From TABLE 21 
& FIG 22). 
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TABLE 22: ARCHITECTURE ANALYSIS IN CONVENTIONAL 
SMEAR & CELL BLOCK: 
ARCHITECTURE 
CONVENTIONAL 
SMEAR 
CELL 
BLOCK 
INFERENCE 
Minimal 20 10 
Pearson Chi-
square 
0.000 
Moderate 80 75 
Excellent 0 15 
 
Conventional smear analysis of 100 smears showed 80 cases had 
moderate architecture and 20 cases had minimal architecture. 
Whereas by cell block, 15 cases had excellent architecture resembling 
histology, 75 cases had moderate architecture and 10 cases had minimal 
architecture (From TABLE 22 & FIG 23). 
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TABLE 23: OVERALL COMPARISON OF DIAGNOSIS: 
 
DIAGNOSIS 
CONVENTIONAL 
SMEAR 
CELL BLOCK INFERENCE 
Benign 66 71 
Pearson Chi-
square 
0.000 
Suspicious 8 0 
Malignant 15 24 
Nondiagnostic 11 5 
 
By conventional smear 66 cases were benign, 15 were malignant, 8 
cases were suspicious of malignancy and non-diagnostic in 11 cases. 
By cell block 71 cases were benign, 24 cases were malignant, 5 cases 
were non-diagnostic and suspicious in none (From TABLE 23 & FIG 24). 
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IMMUNOHISTOCHEMICAL ANALYSIS: 
IMMUNOHISTOCHEMICAL ANALYSIS OF MALIGNANT 
PLEURAL EFFUSION: 
 Of the 6 cases of malignant pleural effusion, in 2 cases the primary 
was known to be breast carcinoma which showed positivity for estrogen 
receptor, negative for TTF-1 which confirmed the diagnosis of metastatic 
breast carcinomatous deposit. In one case of ovarian carcinoma, cell block of 
pleural fluid showed malignant cells which was confirmed by 
immunohistochemistry. 2 cases were positive for TTF-1, CK 7 and negative 
for calretinin and CK 20, confirming the diagnosis of adenocarcinoma of the 
lung. 1 case of metastasis from adenocarcinoma TTF-1, CK 7, CK 20 was 
negative but the morphology and the architecture of the cells gives a 
definitive diagnosis of adenocarcinoma. 
TABLE 24: PRIMARY SITES OF MALIGNANT PLEURAL 
EFFUSION 
S.NO PRIMARY SITE NO.OF CASES PERCENTAGE 
1 Breast 2 33.3% 
2 Lung 2 33.3% 
3 Ovary 1 16.6% 
4 Unknown 1 16.6% 
 Total 6 100% 
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IMMUNOTYPING OF MALIGNANCY CASES IN BRONCHIAL 
WASH: 
Out of 9 malignant cases reported by cell blocks of the bronchial wash 
specimens, immunohistochemistry was done in 4 cases.3 cases (three 
squamous cell carcinomas), a confident cell type was established by 
morphology in the cell block and immunohistochemical staining was done 
(p63 and pancytokeratin positive) which was in agreement with the 
histological classification. 
In one case of small cell carcinoma both conventional smear and cell 
block showed abundant cellularity with excellent morphological features but 
negative for all the immunohistochemical markers.  
IMMUNOTYPING OF MALIGNANCY IN THE CELL BLOCKS OF 
FNAC: 
         There were 9 cases of malignancy diagnosed on cell block. Among 
these 9 cases, 4 cases had adequate material to perform 
immunohistochemistry. The panel of markers used are p63, TTF-1, 
synaptophysin, pancytokeratin. 
In 2 cases where a confident cell type had been established by 
morphology in the cell block the immunohistochemical staining was in 
agreement (p63 and pancytokeratin positive) and correlated with the 
histological classification. 
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One case reported as poorly differentiated carcinoma by conventional 
smear was confirmed to be small cell carcinoma by immunohistochemistry 
oncell block which showed synaptophysin positivity pancytokeratin 
negativity and confirmed the diagnosis of small cell carcinoma. 
In one case, where the morphological features were suggestive of 
poorly differentiated carcinoma, the immunohistochemical profile was done. 
The tumor cells were negative for TTF1, p63 and CK5/6, precluding any 
specific comment on probable cell type. 
DISCREPANCIES OBSERVED IN DIAGNOSIS BETWEEN BOTH 
CS AND CB IN THIS STUDY: 
TABLE 25: Discrepancies observed in pleural effusion: 
CONVENTIONAL SMEAR CELL BLOCK 
Benign Suspicious Malignant 
Non 
diagnosti
c 
Benign Suspicious Malignant 
Non 
diagnostic 
4 - - - - - 3 1 
- - 1 - 1 - - - 
- 3 - - 3 - - - 
- - - 4 4 - - - 
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In the present study (from table 25), Of the 50 pleural effusion cases, 
12 cases showed discrepancies in diagnosis between conventional smear and 
cell block.4 samples were diagnosed to be benign by conventional smear of 
which 3 were diagnosed to be malignant by cell block and 1 case was non-
diagnostic.Of the 3 benign cases, 2 were diagnosed to be benign due to 
decreased cellularity in the smear, but in cell block the cellular yield was 
more with good preservation of morphology and architecture which led to 
the definite diagnosis of malignancy. By immunohistochemistry, they 
showed positivity for estrogen receptor and negative for TTF-1. In another 
case, the background was obscured by inflammatory cells and reactive 
mesothelial cells on conventional smear which was clear on cell block, 
leading to the diagnosis of malignancy.1 case was reported as malignant 
effusion on conventional smear showed very few malignant cells on cell 
block which was not adequate for diagnosis. Subsequently, 
immunohistochemistry also was negative for ER and TTF-1. 
In 3 cases morphology was not well preserved in conventional smear 
and a few suspicious clusters were seen in cell block and were reported as 
suspicious of malignancy. Immunohistochemistry was done in the cell block. 
All the 3 cases showed positivity for calretinin and negative for TTF-1, CK 
and the cases were reported as reactive mesothelial hyperplasia. 1 case which 
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was considered benign by smear was non-diagnostic in cell block and 4 
cases non-diagnostic in smear was diagnosed benign in cell block. 
TABLE 26:DISCREPANCIES OBSERVED IN BRONCHIAL WASH: 
CONVENTIONAL SMEAR CELL BLOCK 
Benign Suspicious Malignant 
Non 
diagnostic 
Benign Suspicious Malignant 
Non 
diagnostic 
2 - - - - - 2 - 
- 2 - - 2 - - - 
- - - 3 3 - - - 
 
2 cases of bronchial washings, reported to be benign on conventional 
smear showed malignant clusters on cell block and was reported to be 
malignant (From table 26). Based on the morphological features in the cell 
block 1 case was reported as squamous cell carcinoma and the other case as 
large cell carcinoma. 2 cases of bronchial washings were suspicious on 
conventional smear confirmed to be metaplastic squamous cells on cell block 
due to increased cellularity and morphology. 3 cases which were non-
diagnostic by conventional smear were reported as benign by cell block. 
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TABLE 27: DISCREPANCIES OBSERVED IN FNAC SAMPLES: 
CONVENTIONAL SMEAR CELL BLOCK 
Benign Suspicious Malignant 
Non 
diagnostic 
Benign Suspicious Malignant 
Non 
diagnostic 
2 - - - - - 2 - 
- 3 - - - - 3 - 
2 cases of FNAC diagnosed as benign on conventional smear had 
malignant cells on cell block due to better cellular yield and morphology 
(From table 27). 3 cases of FNAC, suspicious on conventional smear due to 
atypical cells were confirmed to be malignant on cell block due to better 
cellular yield and morphological preservation. 
TABLE 28: AGREEMENT MATRIX FOR CONVENTIONAL SMEAR 
AND CELL BLOCK: 
 
PLEURAL 
FLUID 
BRONCHIAL 
WASH 
FNAC 
SMEAR POSITIVE, 
CELL BLOCK POSITIVE 3 7 4 
SMEAR NEGATIVE, 
CELL BLOCK POSITIVE 3 2 2 
SMEAR POSITIVE, 
CELLBLOCKNEGATIVE 1 0 0 
SMEAR NEGATIVE, 
CELLBLOCK NEGATIVE 32 21 5 
Sensitivity – 93.3%   Sensitivity – 93.3% 
Positive predictive value – 58.3% Negative predictive value – 98.68% 
  
  
 
        
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
FIG 25:Conventional smear showing  
singly scattered tumour cells. 
 (H & E, 10x) 
Fig 26:Cell block showing  high 
cellularity in a localised area (H & E, 
10x) 
Fig 27: Cell block showing malignant cells arranged in 
acini and papillary pattern  (H & E, 10x) 
         
 
 
 
       
 
      
Fig 29: Photo micrograph showing 
mesothelial cells arranged in acini in 
cell block (H & E, 40 x) 
Fig 30: Mesothelial cells showing 
calretinin positivity in cell block (40 x) 
Fig 31: Conventional smear showing 
a cluster of suspicious cells ( H& E, 
40x) 
Fig32:  Cell block showing malignant 
cells arranged in acini and with well 
preserved morphology in same case. 
( H& E, 40x) 
  
        
 
 
 
        
 
 
  
Fig 33: Conventional smear showing 
malignant cells obscured by 
hemorrhage in bronchial wash .(H & 
E, 10x) 
Fig 34: Cell block showing malignant 
squamous cells with well preserved 
morphology in bronchial wash of the 
same case. (H & e , 40 x) 
Fig 35: Malignant squamous cells 
showing nuclear positivity for p63in 
cell block (40 x) 
Fig 36: Cell block showing malignant 
squamous cells positive for 
pancytokeratin (40 x) 
  
 
    
    
 
 
 
    
    
 
 
  
Fig 37: Cell block showing metastatic ovarian carcinoma cells in pleural effusion 
(H & E, 40x) 
Fig 38: Cell block showing  malignant cells positive for CK 7 in malignant 
pleural effusion (40 x) 
  
 
 
 
 
 
 
 
  
 
 
 
        
 
  
Fig 42: Conventional smear showing 
singly scattered malignant cells in 
pleural effusion  (H & E, 10 x) 
Fig 43: Cell block showing high 
cellularity and well preserved 
malignant cells in pleural effusion (H 
Fig : 44 Cell block showing 
Malignant cells positive for CK 7 in 
adenocarcinoma of lung Low Power 
(10x) 
Fig : 45 Cell block showing 
Malignant cells positive for CK 7 in 
adenocarcinoma of lung High Power 
(40x) 
        
 
 
 
       
 
  
  
  
  
Fig 39: Conventional smear showing 
singly scattered malignant cells in 
pleural effusion (H & E, 10x) 
Fig 40: Cell block showing high cellularity 
of metastatic breast carcinoma cells in 
pleural effusion (H & E , 40 x) 
Fig 41: Cell block showing malignant cells in pleural effusion 
positive for estrogen receptor  (40 x) 
        
 
 
 
       
 
  
  
  
Fig46: Conventional smear showing  
malignant cells  of small cell 
carcinoma in a dirty background in 
imaging guided FNAC (H & E, 40x) 
Fig 47: Cell block showing  cluster of  well 
preserved malignant  cells in small cell 
carcinoma (H & E, 40x) 
Fig 48: Cell block showing malignant cells of small cell carcinoma 
positive for synaptophysin – imaging guided FNAC (40x) 
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DISCUSSION 
Cell-blocks work as an adjunct tool to conventional smears for 
establishing a definitive cytopathologic diagnosis. Several authors have 
reported the advantages of cell blocks in cytology which includes valuable 
diagnostic evidence that cannot be observed in smears
1, 3
. 
In this study, routine conventional smears and cell block from pleural 
fluid, bronchial wash and residual FNAC material from pulmonary lesions 
were compared for cellularity, architecture, cytological preservation and its 
diagnostic utility. 
The objective of this study is to evaluate the utility of the routine use 
of cell block by assessing the concordance in diagnosis between 
conventional smear and cell block and the possibility to perform ancillary 
studies in cell blocks. 
 In this study,plasma thromboplastin method of cell block preparation 
is used to prepare cell blocks from pleural fluid, bronchial wash and residual 
FNAC samples. This is similar to the study done by Castro-Villabón D et al 
and Kulkarni et al which also used plasma thromboplastin method of cell 
block preparation
70,93
. 
 Of the 100 cases, 50% of the sample was pleural effusion, 35% of 
bronchial wash and 15% of image guided FNAC from the pulmonary 
lesions. 
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Pleural fluid: 
Of the 50 samples of the pleural fluid, the maximum numbers of 
samples were in the age group of 41-50 years accounting for 26%.  
Abundant cellularity was seen in 14% of the cases by conventional smear, 
while by cell block it was 44%. A study by Bista et al had 56.8% of the cases 
with abundant cellularity by cell block which is slightly higher than the 
present study
92
. 
 Excellent architecture resembling histology by conventional smear 
was seen in none, but by cellblock it was seen in 8%. In the present study, 
cell block showed architecture with excellent resemblance to histology with 
glandular structures, papillary structures, three dimensional clusters and 
prominent signet ring cells, more reliably seen by the cell block method. The 
study done by Bhanvadia et al also states that, the benefit of cell block 
technique is the recognition of histologic patterns of disease that sometimes 
cannot be reliably identified in smears preparations but can be more reliably 
seen in cell block method
98
. 
In this study, conventional smear showed 84% of adequate smear, of 
which 6% were diagnostically superior. Whereas, by cell block method the 
adequacy of 94% was observed, of which 34% were diagnostically superior. 
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TABLE 29: COMPARISON OF QUALITY OF CELL BLOCK WITH 
OTHER STUDIES 
QUALITY  IN 
CELL BLOCK 
SUPERIOR% ADEQUATE% UNSUITABLE% 
THAPAR et al(2009) 67 21 12 
NATHANI et al(2014) 25 55 20 
PRESENT STUDY 34 60 6 
 
In a study by Richa Nathani et al, 25% of the cases were 
diagnostically superior and the study by Thapar et al, had higher number of 
diagnostically superior cases accounting for 67%
94,89
. The percentage of 
diagnostically unsuitable cases by cell block is 6% which is very less when 
compared to the study by Richa Nathani et al which had 20% and Thapar et 
al which had 12% of diagnostically unsuitable cases
89
. 
The cell block preserves more cellular material from the sample, the 
statistical difference in cellularity, architecture and quality of smear between 
the two methods shows a ‘p’ value of 0.006, 0.000 and 0.001 respectively, 
which is very significant.  
Of the 50 pleural effusion cases, the majority (80%) of the cases were 
benign effusion by cell block.In the present study, malignancy was 
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diagnosed in 8% of the cases by conventional smear and in 12% of cases by 
cell block. 
TABLE 30: COMPARISON OF DIAGNOSIS BY CELL BLOCK 
WITH OTHER STUDIES 
DIAGNOSIS 
BY 
CELL BLOCK 
BENIGN 
% 
SUSPICIOUS 
% 
MALIGNANT 
% 
NONDIAGNOSTIC 
% 
Bhanvadia et 
al 
 
78 0 22 0 
RichaNathani 
et al 
85 0 15 0 
PRESENT 
STUDY 
80 0 12 8 
The ‘p’ value is 0.000 which shows a very significant difference 
between the two methods. Thus cell block yields higher malignancies which 
were missed by conventional smears. 
In this study among the malignant effusion diagnosed by cell block, 
carcinoma of lung in males and metastatic effusion of carcinoma breast in 
females were commonest each accounting for 33.3%, followed by ovarian 
carcinoma (16.6%) and unknown primary (16.6%).Inkhan et al study, 
carcinoma of lung was the commonest site followed by carcinoma of ovary 
and carcinoma of GIT
90
. Similarly Murphy et al, study described that the 
commonest primary malignant lesions were in the breast followed by lung 
and ovary
91
. 
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Bronchial wash: 
Of 35 casesof bronchial washings maximum number of sample were 
in the age group of 61-70 years accounting for 34.28%.Abundant cellularity 
by conventional smear was seen in 8.57% of cases but by cell block it was 
17.4%. Excellent architecture resembling histology by conventional smear 
was seen in 8.57% but by cellblock it was seen in 17.14%. The overall 
quality of smear by conventional method was superior in none of the sample 
but by cell block it was superior in 14.28%.Though cell block preserves 
more cellular material from the sample,the difference in cellularity, 
architecture and quality of smear between the two methods shows a ‘p’ value 
which is statistically insignificant.  
Malignancy was diagnosed in 20% of the casesby conventional smear 
and in 25.71% of cases by cell block. Thus cell block has increased the 
diagnostic yield of malignancy by 5.7%.The ‘p’ value is 0.000 which shows 
a very significant difference between the two methods. 
TABLE 31:Comparison of increase in yield of malignancy with other 
studies 
 
Flint et 
al(1993)
95 
Calabretto et 
al(1996)
96 Present study 
Increase in  
Malignancy yield 
9% 6.5% 5.71% 
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Out of 35 cases, 20% of the cases were malignant which includes 
88.8% (8/9) of squamous cell carcinoma and 11.1% (1/9) of 
adenocarcinoma. Immunohistochemistry was performed in 44.4% of 
malignant cases in which adequate material was available in the cell block 
and subtyping of the tumor was confirmed.  
FNAC: 
Of the 15cases of residual material from fine needle aspiration 
cytology(FNAC) done for pulmonary mass lesions, the maximum numbers 
of samples were in the age group of 61-70 years accounting for 40% of the 
samples. 
 By conventional smear none of the sample had abundant cellularity 
but by cell block 20% of the samples had abundant cellularity.Excellent 
architecture resembling histology by conventional smear was seen in 6.66%, 
but by cellblock it was seen in 33.33%. The quality of smear by conventional 
method was superior in none of the sample but by cell block it was superior 
in 40%. Though the cell block preserves more cellular material from the 
sample, the statistical difference in cellularity show a ‘p’ value of 0.574, 
which is statistically not significant. But the architectureand quality of smear 
show a ‘p’ value of 0.026 and 0.001 respectively, which is statistically 
significant. 
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In the 15 samples, a definitive diagnosis of malignancy was made by 
conventional smear in 26.66% and by cell block in 60%.  In a study 
conducted by Nathan NA et al, 42.2% of the cases were diagnosed to be 
malignant by cell block
31
. 
TABLE 32: Comparison of diagnosis by cell block with other studies 
Diagnosis by cell block Benign Suspicious Malignant Non-diagnostic 
Nathan NA et al
31
, 2000 
n=465 
6.2% 5.2% 42.2% 46.4% 
Present study n=15 33.3% 0 60% 6.66% 
The ‘p’ value is 0.001 which shows a very significant difference 
between the two methods. Thus cell block yields higher malignancies which 
were missed by conventional smears. 
In this study, 55.5% of squamous cell carcinoma, 22.2% of 
adenocarcinoma and 11.1% of small cell carcinoma and large cell carcinoma 
each was diagnosed based on the morphological features of the malignant 
cells in the cell block. Immunohistochemistry was performed in 33.3% of the 
cases to confirm the subtyping of the malignancy. 
In this study, squamous cell carcinoma is the most common subtype 
accounting for 72.2%. Sinard et al also has reported that squamous cell 
carcinoma (72.2%) is more common than adenocarcinoma (16.6%). 
W.A.H.Wallce et al states that, a slight bias towards squamous carcinoma 
 105 
 
contributes to the overall accuracy of cell typing by morphology, as 
evidenced by keratinization- a reliable indicator of squamous 
differentiation
97
. In contrast, the identification of adenocarcinoma often 
requires architectural clues that are less often present in cytology samples. 
In the present study of 100 cases, cell block showed abundant 
cellularity in 31% of the cases which is higher than that of the conventional 
smear which showed abundant cellularity in only 10% of the cases. In the 
study by Castro-Villabón D et al abundant cellularity in cell block was seen 
in 29.6% of the cases which is equal to our study. In the present study, cases 
with minimal cellularity were 8%. Castro-Villabón D et al had 37.4% of 
cases with minimal cellularity which is higher than that of the present study. 
TABLE 33: Comparison of overall cellularity by cell block in the 
present study with other studies 
 
CELLULARITY IN 
CELL BLOCK 
ABUNDANT 
% 
SUFFICIENT 
% 
MINIMAL 
% 
Castro-Villabón D et al 29.6 33 37.4 
PRESENT STUDY 
31 61 8 
 The quality of conventional smear and cell block was assessed by 
using the point scoring system by Mair et al. In this present study, 
conventional smear showed 86% of adequate smear, of which 3% were 
diagnostically superior. Whereas, by cell block method the adequacy of 95% 
was observed, of which 28% were diagnostically superior. The ‘p’ value of 
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cellularity, background and architectural difference between conventional 
smear and cell block is 0.000. The ‘p’ value of morphology is 0.001. Hence 
statistically, there is a highly significant difference in overall quality between 
conventional smear and cell block. 
In the present study Of the 100 cases, 71% were benign and 24% were 
malignant. 76% of the cases had similar diagnosis both in conventional 
smear and cell block and discrepancies were seen in 16% of the cases. 
TABLE 34: Comparison Of Diagnostic Concordance 
Study Diagnostic concordance (%) 
Castro-Villabón D et al,2014 81.6 
Kulkarni et al,2009 94 
Present study 76 
The diagnosis of malignancy by conventional smear was 15%, which 
increased to 24% with the cell block method. The additional yield of 
malignancy by this study is 9%.  Thus cell block yields higher malignancies 
which were missed by conventional smears. The ‘p’ value by Pearsons Chi-
square test is 0.000. Hence there ishighly significant difference in diagnosis 
between conventional smear and cell block. 
Of the 16% of the cases with discrepancies includes 7 cases 
considered as benign by conventional smear were confirmed to be malignant 
by cell block.5 cases suspicious of malignancy and 1 cases considered as 
malignant by conventional smear were diagnosed to be benign by cell block. 
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3 cases suspicious of malignancy on conventional smear were diagnosed as 
malignant by cell block.  
Immunocytochemistry studies were performed in 18% of cases. The 
markers used in order of frequency were: p63, TTF-1, calretinin, CK7, 
CK20, Synaptophysin, estrogen receptor, pancytokeratin. Of these 
immunohistochemistry was confirmatory in 86.6% of the cases.  
 108 
 
SUMMARY 
In this prospective study of 100 samples, 50 were pleural fluid, 35 
were bronchial wash and 15 were residual material from imaging guided fine 
needle aspiration cytology (FNAC) of lung.These cases were evaluated by 
simultaneous use of smear and cell block technique. Immunohistochemistry 
was done on cell blocks whenever needed. 
With each sample received conventional smear was made and the 
remaining sample was subjected for cell block preparation by plasma 
thromboplastin method. The comparison of the smear and cell block was 
made on the basis of cellularity, architecture, morphology and diagnosis. 
Abundant cellularity was seen in 31% of the cases by cell block and only 
10% of the cases had abundant cellularity by conventional smear. Excellent 
architecture equivalent to histology was seen in 15% of the cases by cell 
block and this was not seen in conventional smear. Concordance in diagnosis 
between conventional smear and cell block was seen in 76% of the cases. 
Combining both conventional smear and cell block, the diagnostic yield of 
malignancy increased by 9%. Immunohistochemistry was performed in 18% 
of the cases to confirm and subtype the malignancy. 
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CONCLUSION 
The cell block technique by plasma thromboplastin method is a simple 
cost effective technique and does not require any special training or 
instruments. This technique can be used in routine practice for cytological 
diagnosis. The cellularity and morphological features is better preserved in 
cell block method than conventional smear. By cell block method 
architectural pattern resembling that of histology is identified. Multiple 
sections can be obtained for immunohistochemistry to confirming and sub-
type the malignancy. The accuracy of the diagnosis and yield of malignancy 
was increased when cell blocks are used along with the conventional smear 
method.Cell block is a very good adjunct to conventional smear study in the 
better yield of cellularity and architecture with an advantage to do 
immunohistochemistry, leading to better diagnosis of malignancy in the 
fluids and residual FNAC samples of pulmonary lesions.Ideally cell block 
technique should be used in routine practice for cytological diagnosis. 
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ANNEXURE- I 
PROFORMA 
S.No: 
Name:                                                            Age:                 Sex: 
Hospital Ip/Op no: 
Address of the patient: 
Contact phone no: 
Clinical details: 
Investigations: 
Clinical diagnosis: 
Type of sample: Pleural Fluid/ Bronchial Wash/ Image Guided Fnac 
Cytology no: 
Conventional smear findings: Cellularity/ Architectural pattern/ 
Cytomorphology/ Background 
Cell block findings: Cellularity/ Architectural pattern/ Cytomorphology/         
Background 
Immunohistochemistry (if needed): 
Impression:    
 
  
ANNEXURE II 
CONSENT    FORM 
I have been informed in detail (verbal and written)from the doctor in 
our own language regarding the study. I hereby give consent to use the 
sample material for Dr. S.Saranyaa’s thesis as a part of the MD degree  
curriculum. I have no objection to her publishing details of this study in 
medical journal after its completion. I understand that I have the liberty to 
withdraw from this study at any stage. 
 
 
 
 
 
 
 
 
DATE: 
Cytology NO:                                                          
                                                                          Signature: 
                                                                          Name of the patient: 
                                                                          Addresss: 
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KEY TO MASTER CHART 
C – CELLULARITY 
  0 - Minimal or absent: Diagnosis not possible 
 1 - Sufficient for cytodiagnosis 
 2 - Abundant : Diagnosis simple 
B – BACK GROUND OBSCURED BY BLOOD AND PROTEINACEOUS 
MATERIAL 
 0 - Large amount: Diagnosis greatly compromised 
 1 - Moderate amount: Diagnosis possible 
 2 - Minimal amount: Diagnosis easy 
M – MORPHOLOGY cellulardegeneration and cellular trauma. 
 0 - Marked: Diagnosis impossible 
1- Moderate: Diagnosis possible 
2 - Minimal: good preservation 
A – ARCHITECTURE appropriatearchitecture and cellular arrangement 
 0 - Minimal to absent: nondiagnostic 
 1 - Moderate: some preservation eg: follicles, papillae,acini, synctia or  
     single cell pattern 
 2 - Excellent architectural display, closely reflectinghistology:   
     diagnosis obvious 
QUALITY 
Diagnostically unsuitable (score 0-2) 
Diagnostically adequate (score 3-6) 
       Diagnostically superior (score 7-8) 
